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Abstract 
 
Objectives: Orthopaedic and dental implants are prone to frequent infections. This 
can lead to detrimental and often irreversible outcomes for many patients. The 
objective of this study was to develop a novel system using zinc oxide nanoparticles 
(nZnO) as a coating material that inhibits both bacterial adhesion / growth and 
promotes osteoblast growth.  
 
Methods and Results: Initially bacteria (S. aureus, E. coli, S. epidermidis and P. 
aeruginosa) were exposed to different concentrations of zinc oxide nanoparticulate 
suspensions (250 µg/mL, 500 µg/mL, 1000 µg/mL and 2500 µg/mL); with the higher 
concentrations of the suspensions demonstrating significant bactericidal effects. A 
novel electrohydrodynamic atomization coating technique (EHDA) was used to 
deposit mixtures of nZnO and nano-hydroxyapatite (nHA) onto the surface of glass 
samples (1 cm2). Exposure of the coated samples to phosphate buffered saline (PBS) 
and adult bovine serum (ABS) and measurement of bactericidal activity 
demonstrated superior antimicrobial activity for 100% and 75% nZnO composite 
coated samples. Lactate dehydrogenase (LDH) release from osteoblast-like cells 
(UMR-106 and MG-63) exposed to both nano-TiO2 and nano-ZnO nanoparticulate 
suspension supernatants indicated minimal toxicity. Nano-ZnO coated samples did 
not elicit LDH release with an increase in proliferation and viability of cells was 
observed. Scanning electron microscopy (SEM) and optical microscopy indicated 
that all cell types used (mesenchymal stem cells and osteoblast-like cells) were able 
to maintain their normal morphological state when adhered to the surface of the 
nano-coated material. Further studies as regards to patterned coated samples showed 
an exclusive adhesion selection by osteoblast-like cells to nZnO patterned regions 
that needs to be further investigated. 
 
Conclusion: ZnO NPs provide an antimicrobial and biocompatible coating material 
for medical and dental bone implants 
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This illustration summarises the main findings of the present thesis – These findings are 
related to enhanced antimicrobial activity of the coatings and the nanoparticulates and also 
their biocompatibility and osteoconductive nature. The pictorail representaion is intended to 
showcase and breifly highlight the main findings to provide an overview of the work for the 
reader.  The pseudo-coloured cells depict two healthy communicating cells on a nano-coated 
surface.  
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Thesis summary 
Chapter 1 – Literature review 
A literature review based upon the current and past research carried out on the 
subject of nanoparticles and their role in providing antimicrobial effects. This section 
covers topics on antibiotic resistance, biofilm formation together with the challenges 
that are often faced when dealing with these issues. Furthermore an overview of the 
application of different coating methodologies is provided and discussed. 
Chapter 2 – Investigations into the antimicrobial activity of nano-metal oxides 
The initial section of this chapter is based upon the introduction and optimisation of 
the utilised coating technique. The coating process is carried out by the novel 
technology of EHDA. In order to achieve the desired outcome, that is defined by a 
uniform nano-based coated surface, different parameters such as height of the nozzle 
from the substrate, voltage and the flow rate of the nanoparticulate suspension were 
investigated. The outcomes were then assessed using imaging systems. Furthermore, 
this section also deals with the antimicrobial activity of the nanoparticulates tested. 
The bactericidal effect of these nano-coated structures is qualitatively and 
quantitatively measured and a suitable particulate was chosen based upon careful 
deductive investigations, supported by experimental evidence.  
Chapter 3 – Nano-ZnO as an implant coating material 
This section provides background information on how bone forming cells 
(osteoblasts) respond to the selected nanoparticulate under altering conditions. The 
objective in this chapter is to demonstrate the non-toxic, biocompatible and 
osteoconductive nature of these coatings.  
Chapter 4 – Future innovations 
This section provides preliminary evidence for various novel applications of nZnO. It 
also explores the potential of testing coated surfaces in a novel setup where shear 
stress based on fluid movements will test for durability of NPs on treated surfaces. 
Additional initial investigations such as hydrogen peroxide and ion release 
capability, together with the role of patterned coated surfaces on cell behaviour are 
investigated. This chapter serves as a guide for a further coherent study research. 
Chapter 5 - Discussion 
General discussion on the outcome of the present research and how collectively all 
its components provide valuable insights for the development of an antimicrobial 
bone device that is potentially superior to products that are currently available in the 
fields of dentistry and medicine. 
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Chapter 1 
1. Literature review 
1.1 Nanotechnology: a historical perspective 
The general idea that small synthetic materials can be used for humans in order to 
provide health related benefits for humans is an odd idea. Many consider Richard 
Feynman, the celebrated physicist, as the father of nanotechnology (Peterson, 2004), 
an individual who proposed the use of such small scaled materials. During a 1959 
lecture, Feynman stated that tiny robot like constructions can be used for a variety of 
medical conditions; these nano-machines will eventually interact at atomic scale and 
can have a potential positive impact on our health. In addition, he suggested that it is 
rather probable that in future mankind will be able to fit the entire Encyclopaedia of 
Britannica on top of a needle, referring to storage of information in nano-scale. This 
idea is widely known as the Feynman vision or thesis.  In his lecture, Feynman 
hinted at several possibilities for these breakthroughs, such as “mechanical surgeons” 
and “small computers” (Feynman, 1960).  These ideas were not thought of 
revolutionary at the time of the lecture and it wasn’t until a decade later that 
scientists initiated their attempts at addressing the Feynman thesis. In fact the term 
“nanotechnology” was not devised by Feynman during his lecture and only 15 years 
post his famous lecture, a Japanese scientist named Norio Taniguchi suggested that 
technology “strives for precision” at the small scale of a nanometre. With the help of 
the advancing technology and subsequent innovative breakthroughs, the science of 
nanotechnology also thrived. A prime example of this is utilising the 1981 scanning 
tunnelling microscope (Binnig et al., 1985). This device allowed for a type of 
precision microscopy that permitted experts to detect the approximate height of 
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individual atoms, this then made a company like IBM to write the individual letters” 
I”, “B” and “M” at atomic scale for the first time, beginning a new era for computing 
(Eigler and Schweizer, 1990).  
1.2 Nanomaterials in medicine 
Mainstream approaches to nanotechnology are now mostly focused on material 
sciences allowing for the application of nanomaterials to a vast number of products 
(Roco, 2004). Nanomaterials/Nanoparticles (NPs) are often divided into two distinct 
categories: organic and inorganic (Liong et al., 2008). Organic nanomaterials may 
include carbon NPs and liposomes whereas inorganic NPs include noble metals such 
as gold and silver and others which possess semi conductive properties, i.e. Titanium 
dioxide. These NPs maybe used for multiple applications such as diagnosis, 
therapeutics and drug delivery.  
Organic NPs such as liposomes are known for their excellent biological properties, 
allowing them to diffuse and penetrate cells for drug delivery purposes (Torchilin, 
2005). Carbon nanotubes on the other hand exhibit mechanical as well as electrical 
properties which makes them suitable for applications such as biosensors and anti-
cancer (Logothetidis, 2006b). However, inorganic NPs are having a greater impact 
on diagnostic and medical sciences. They are being used as contrast agents for 
imaging techniques such as MRI and X-ray where used in low doses, tissue-specific 
targeting as well as imaging of the circulatory systems can be achieved (Na et al., 
2009). They are also used as biological markers and as for probes for studying the 
structure of DNA among other complex and highly sophisticated molecules and 
experimental settings (Logothetidis, 2006a). Therefore, NPs can be used in line with 
other conventional methods for enhanced integration of bone to metal based 
prostheses. These devices can be designed in a way to enhance the interaction 
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between the existing surface and that of the living tissue (Singh and Manikandan, 
2011). 
 
Both orthopaedic and dental implants are also susceptible to failure due to a variety 
of causes with bacterial infection being of particular concern (Mack et al., 2006, 
Otto, 2013). This occurs despite extensive measures to reduce such infections. There 
are an increasing number of patients requiring medical devices, such as artificial 
joints to enable everyday activity. An improvement of current implants, i.e. 
infection-resistant prostheses, will offer tremendous benefits to countless patients. A 
common means by which these devices are exposed to infections is during surgical 
procedures. This is most probably due to the presence of nosocomial pathogens and 
although careful aseptic methods are usually followed by most hospital personnel 
and surgeons, these types of infections remain unchallenged. The official report 
(Surveillance of Surgical Site Infections in NHS hospitals in England 2013/14) for 
orthopaedic related infections suggests that in the UK alone there are various cases of 
patients whom acquire infections post-operatively. Although the incidents of 
contamination have decreased in orthopaedic related procedures between years 
2008/09 and 2013/14, the challenge of total prevention still remains. This report 
suggests that patients who leave the hospitals and readmitted are at a greater risk of 
infection. The predominant species in orthopaedic related operations (hip, knee, 
repair of neck of femur and spinal related surgery) was Staphylococcus aureus, 
causing ≥ 40 % of all infections.  Because of this the issue of orthopaedic related 
infections in nosocomial environments is still a major concern. Some medical 
devices incorporate antibiotics to help resist infection, however due to certain 
limitations for example, decreased release at the later stages of implantation, 
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resistance continues to rise (Aviv et al., 2007). Antibiotics have been used to combat 
these infections for many years but as a result of over-use and over-prescription, 
bacteria have evolved mechanisms to avoid their effects with microbial resistance 
rising significantly (Normark and Normark, 2002). Therefore development of 
innovative methods which deliver an alternative approach to antimicrobial function 
is therefore much in demand.  In particular, the potential of antimicrobial NPs as 
future agents has received much attention (Rai et al., 2009).  The antimicrobial 
activities of NPs vary depending on their structure and chemical composition. Their 
recent applications in tissue engineering and bone related research has gained 
considerable attention (Harrison and Atala, 2007, Corchero et al., 2010). 
Furthermore,  these agents hold physiochemical properties that makes them unique 
among all antimicrobials (Albers et al., 2013). Their shape, increased surface area 
and size, combined with their toxic nature towards prokaryotic organisms make them 
extremely attractive as multifunctional agents (Salata, 2004).  
Findings in the current study suggests that composites of hydroxyapatite (HA) and 
zinc oxide NPs (nZnO) are a possible choice as a prospective coating material for 
future orthopaedic implants (Zhao et al., 2013).  
As coatings for medical bone implants gradually advance, a niche for products that 
outperform the previous generation of biomaterials is often created. Hydroxyapatite 
in its nano form (nHA) is a direct result of such evolution (Bryington et al., 2013). 
This material is understood to increase osteoblast function, proliferation, collagen 
production as well as osteoblast morphology (Shi et al., 2009b) Conventional coating 
methods such as plasma spraying utilise extreme heat that can change properties of 
NPs. However, such procedures often result in the production of a rough, thick (40-
50 µm) and uneven surface (Sun et al., 2001).  Therefore by applying a method that 
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allows for formation of a homogenised, micro-fabricated coating, it has been possible 
to produce layers of nano-coatings that are thin, homogenised and stable in nature.  
This unique quality allows for the exposure of groups of NPs to both bacteria and 
osteoblasts which may directly result in unique outcomes not achievable by 
conventional coatings. The combination of this novel approach with the advantage of 
zinc being an important trace element can be distinctively useful for bone related 
implants. More recently, it has been demonstrated that the addition of ZnO to bone-
composites can enhance the proliferation, adhesion and differentiation of osteoblasts 
(Li et al., 2010)  . Furthermore, zinc embedded calcium phosphate (CaP) ceramics 
have also been shown to promote the growth of bone cells when compared to non-
embedded Zn CaP ceramics (Ito et al., 2002).  
The antibacterial effects of metallic nanoparticles (MN) (silver (nAg) and nZnO) 
have so far proven to have a long lasting biocidal activity with high thermal stability 
and relatively low toxicity to human cells (Allaker, 2010). Recent studies suggest 
that nZnO is strongly bactericidal, making it suitable as a coating for medical 
implants (Seil and Webster, 2011).  Preliminary observations suggest that this agent 
has a degree of selectivity towards Staphylococcus aureus, a species that is 
predominantly responsible for surgical site infections (Darouiche, 2004). The main 
proposed superiority of NPs compared to conventional antibiotics is their ability to 
instigate bactericidal effects via different routes, namely: ion release, direct contact 
and generation of reactive oxygen species (Padmavathy and Vijayaraghavan, 2008, 
Hernandez-Sierra et al., 2008). The present investigation is designed to help the 
current understanding of the relationship between coated nZnO and conventional 
nHA in relation to pathogenic bacteria and osteoblasts.   
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Orthopaedic related infections are mostly due to the presence of given species 
bacteria. The two main species of bacteria that have been shown to have a significant 
role in these infections are Staphylococcus aureus and Staphylococcus epidermidis 
(Stoodley et al., 2011, Olson et al., 2006).  It is now accepted that Staphylococcus is 
the most frequently found genus of bacteria found on the surface of the skin and the 
mucous membranes (Chiller et al., 2001). Therefore their specific location may allow 
them to attach onto the surface of a specific material (Titanium or Glass) and with 
the right conditions, they initiate biofilm formation (Costerton, 2005). 
Staphylococcus communities have the ability to communicate to one another and this 
can increase their pathogenicity through quorum sensing (Yarwood et al., 2004). 
During the growth phase they release specific peptides to their extracellular 
environment that can result in enabling the release of unwanted invasive factors as 
well as reducing surface adhesion properties.  
The intricacies of the biofilm system have in turn made it difficult for scientists to 
invent new viable strategies to coat medical devices (Meyer, 2003). Aside from 
specific infections such as the dental plaque, medical device related infections are not 
usually shared between species of bacteria or even different strains of the same 
bacteria.  This phenomenon could be due to quorum sensing properties that bacteria 
use to maximise virulence capabilities. It is of interest that infections caused by 
different species of bacteria can have different surgical outcomes, for example, when 
infected with S. aureus these devices need to be replaced more frequently than when 
there is a S. epidermidis infection. Therefore a comprehensive knowledge is required 
when dealing with bacteria that form biofilms on medical devices. 
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1.3 Biofilm formation 
Knowledge as regards the formation and properties of biofilms is growing and it has 
been established that this system plays an important role in protecting the integrity of 
a certain population of bacteria and essentially protects these populations from 
antimicrobial agents. The structures of biofilms are diverse and help bacterial 
population to withstand harsh conditions (Figure 1). These structures have specific 
properties that are essential for bacterial survival, and within them there is a sessile 
community of bacteria that are able to release certain proteins, macromolecules, exo-
polymers, phenol soluble modulin surfactant peptides and more importantly DNA 
(Mann et al., 2009). Evidence suggests that DNA release plays an important role for 
communication between the bacteria (Whitchurch et al., 2002). Furthermore it has 
been observed that, in an effort to make a resistant population, the cells which are 
exposed to an antimicrobial agent don’t normally die due to programmed cell death 
and instead undergo a “ altruistic suicide” phase, whereby they are lysed and their 
contents are released to the surrounding environment (Nedelcu et al., 2011). This 
phenomenon is hypothesised not to be due of the actions of the antimicrobial agents 
per se, it is likely due to an effort to provide a communal resistance as a result of the 
inflicted “stress”. The cells that have survived the intrusion (persistors) are then able 
to use the materials and nutrients released form the dead cells and promote the 
growth of the community. This action allows bacteria to release vesicles that contain 
their genetic information, thereby communicating the presence of danger or the 
presence of an unrecognisable object to the rest of the population.  However there is 
much debate about the relationship of genes and antimicrobial resistance in the 
scientific community that suggests that genes might play less of a role in this process 
than it was previously believed (Stewart and Costerton, 2001). The more exposed a 
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population to an antimicrobial agent, the more resistant it becomes. It is therefore 
essential to have an antimicrobial agent that has the potential to challenge these 
intricacies for prolonged periods of time.  
 
 
 
 
 
 
 
 
  
Staphylococcus species are responsible for most orthopaedic infections and hence 
most biofilm formation. A recent study looking at both Staphylococcus aureus and 
Staphylococcus epidermidis suggest increased resilience to the newest form of 
antibiotics (Campoccia et al., 2006).  Findings suggests that, bacteria in planktonic 
stage (Figure 1-A) can be eradicated, however after a period of 24 h, biofilm 
formation takes place and most antibiotics are not effective. Despite the fact that 
recently used substances such as silver nitrate are shown to have detrimental effects 
against persistent infection with E.coli (Morones-Ramirez et al., 2013) It is inevitable 
that bacteria, given a short period of time, will develop resistance (Percival et al., 
2005). Therefore a plan for prevention rather than direct destruction of the biofilm is 
more desirable (Nishimura et al., 2006). This will be most beneficial, since most 
bacteria can reside on implant coatings during invasive surgical procedures 
(Campoccia et al., 2006). However before tackling the issue of biofilm formation, it 
is of utmost importance to have a thorough knowledge as regards to bone biology, 
Figure 1 - A) Planktonic bacteria attach to a desirable surface, B) Biofilm formation takes 
place, cells begin to communicate and quorum sensing is initialised, C) A mature biofilm is 
formed and there is potential for bacteria to further disperse into their surrounding 
environment. 
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the various factors which contribute to bone formation and its loss. When a specific 
site of bone infection is examined, it immediately becomes evident that an acute 
inflammation site is where most bacteria reside. In addition, other inflammatory 
factors (including leukocytes) contribute to bone destruction. Furthermore, the blood 
supply to bone is disrupted by compression of vascular channels which in turn 
contribute to direct bone necrosis. A region of bone without blood supply can detach 
from its main body and potentially lead to microbial contamination despite various 
antibiotic treatments (Lew and Waldvogel, 2004). Therefore knowing the intricate 
structure of bone allows researchers to devise a system that is suitable for bone 
implants that are antimicrobial. While generally a multidisciplinary approach is 
required for tackling this issue, the following will elaborate on some of these 
important factors. 
1.4 Bone biology 
The structure of bone is complex (Figure 2). Crucial information about bone biology 
can help to devise improved and more efficient implants, both mechanically and 
biologically. Therefore a brief but inclusive look at its relevant structures is presented 
in the following.  
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The macrostructure of bone consists of cortical and cancellous or trabecular bone. 
For implant purposes these two types of bone structures are important. An implant or 
a medical device that is positioned within the structure of the bone is mostly in 
contact with cancellous bone. Whereas external implants are initially introduced to 
external tissues (i.e skin) and cortical bone. The main difference between cortical and 
trabecular bone can be seen in their structure, strength and function. Cancellous bone 
is thought to be the more metabolically active of the two. This type of bone is easily 
remodelled and contains marrow filled pores, nerves and blood vessels. This 
remodelling and modelling is due to the involvement of different factors such as 
Figure 2 - The interior structure of the bone. A) A cross section highlighting the positions of 
both cancellous and compact bone. B) A comparison of the cancellous bone and compact 
bone. Longitudinal tubes like structures embedded within the structure of compact bone are 
Haversian canals that overtime have evolved to carry blood vessels and nerves. In an 
infection scenario, these canals could collapse as a result of bone destruction and lead to 
further complications. Image obtained from: http://goo.gl/SIUv2A (Titled: interior bone 
structure). 
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aging, activity, and different loading properties of bone. Bone implants with the aid 
of calcium phosphates are designed to help preserve this inner structure of the bone 
by encouraging the growth of osteoblasts and creating an environment which is 
“biologically friendly” (Giannoudis et al., 2005). Devices coated with calcium 
phosphates are capable of promoting bone growth by coming into close contact with 
both of these bone types. For extreme surgical cases such as hip replacements or 
dental related procedures, hydroxyapatite or bio-glass coated metallic implants are 
commonly utilised in order to promote bone growth with the aid of modified metal 
surfaces. Three types of eukaryotic cells are responsible for integration between the 
implant’s surface to bone as well as early and late bone formation and resorption, 
(Figure 3). 
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Figure 3 - The intricate relationship between cells responsible for bone formation and resorption. Interaction between 
osteoblasts, osteoclasts and osteocytes is essential for bone formation, its remodelling and development. The balance 
in activity of each stage allows for a healthy bone to form. Image adopted and from: http://goo.gl/ygYv0A (The 
university of Chicago medical centre). 
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These cells are Osteoblasts (as tested in the present study), osteoclasts and 
osteocytes. Osteoblasts derive from mesenchyme and their main role is to produce a 
rich matrix that is subsequently mineralised (Harada and Rodan, 2003). Cells that 
remain deep within the mineralised structure of bone are referred to as osteocytes. 
These cells are solely responsible for bone remodelling as they are able to control the 
activity of both osteoblast and osteoclasts (Aarden et al., 1994). This is achieved by 
making connections with these (osteoblasts and osteoclasts) cells via dendritic 
structures that can be elongated for relatively short distances of approximately 100 
nm. Upon direct physical contact, regulators are released that either inhibit or 
promote the activity of the above cells that ultimately will lead to bone resorption or 
formation. Finally osteoclasts are cells that control bone resorption, which can 
secrete chemicals such as hydrochloric acid and hydrolases that destroy calcium 
phosphates and the collagen fibres respectively, this leads to the loss of bone mass 
that could result in either damage or bone remodelling (Miyamoto and Suda, 2003). 
This remodelling of bone is carried out throughout an individual’s life; therefore the 
presence of cells which respond to the different environmental, as well as structural 
cues, is essential for a healthy skeleton. Healthy bone is also prone to serious 
damage, be it environmental or genetic. One of the prominent challenges faced both 
fields of dentistry and orthopaedics is bacterial infection, which eventually may lead 
to the lack of proper bone mineralisation and eventually bone destruction.  
1.5 Orthopaedic infections 
Orthopaedic implants (devices) are predominantly assisting the general population 
with maintaining their quality of life. However in some cases complications can 
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occur. Among all complications, infections are thought to be the hardest to deal with. 
Orthopaedic related infections comprise of 1 to 13% of these complications, while 
the percentage is rather low, the outcome can lead to serious health risks in patients 
and cause major consequences, such as: immobility, reoccurring acute pain, chronic 
pain and implant failure. Additionally, the National Joint Registry (NJR) for England 
and Wales (2010) reports that in 2009 alone there were 72,432 hip replacements of 
this, 65,229 were first time surgeries and the remaining 7203 were revision surgeries, 
of which more than 3% were infection related. The underlying mechanisms that leads 
to these consequences also disrupt the normal balance between bone formation and 
resorption and in turn the process of remodelling is halted. It is well documented that 
exposure of bacteria, especially Staphylococcus aureus to osteoblasts results in 
manifestation of markers that are recognised as essential for osteoblast growth and 
division (Widaa et al., 2012). Bacterial adhesion to bone prosthesis can be divided 
into two segments: 1) loose attachment and 2) fixed attachment. The initial stage 
comprises of bacteria adhering to the surface of an implant by utilising weak physical 
forces, such as Van der Waals and gravity. These forces allow the loose attachment 
of bacteria, which in turn allows the initial interaction of bacteria and the material 
surface. The fixed attachment comprises of a series of complex processes that 
collectively depend upon the environment, the material surface and the bacterial 
species/genus involved.  At this stage a firmer connection is made that can result in 
biofilm formation. However various essential factors are known to be involved in 
Staphylococcus aureus attachment. These include molecules that are involved in 
immune evasion, bacterial adhesion, anti-inflammatory interactions, biofilm 
formation and cell invasions. Collectively these factors are either released or reside 
on the surface of the microorganism and in S. aureus, approximately 50 genes are 
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involved in encoding for all these factors that lead to pathogenesis (Sittka and Vogel, 
2008). If spread from the surface of the material to bone, the outcome will likely 
cause a reduction in alkaline phosphatase production as well as an abrupt end in 
production of type I collagen, which in turn could indicate both reduced activity for 
both bone formation and resorption. Furthermore, the escape of bacteria from the 
immune system or multiple antibiotic treatments might lead to implant removal and 
ultimately extensive bone removal.  
1.6 Dental infections 
Classification of failure in dental implants is categorised into failing and failed 
implants. The failing implants are treatable and the implant can be saved, whereas 
failed implants need to be removed completely. Infection is one of the factors 
involved that is often related to late failing implants that ultimately lead to total 
failure. The initial bacterial flora involved in early stages of a failing implant is often 
gram-positive, non-motile and facultative in nature. However there is a transition 
from these populations towards one that contains more gram-negative, motile and 
anaerobic bacteria (Alcoforado et al., 1991, Leonhardt et al., 1999). At this stage, an 
inflammatory process that affects the surrounding tissue, peri-implantitis, may occur 
which leads to the loss of the surrounding bone that serves as a support for the 
implant (Pye et al., 2009). Some of the most common bacteria isolated from these 
regions are highlighted in Table 1.  
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In general the process of bone destruction also applies for dental implant infections 
but with a heightened risk of having many more species of bacteria (mostly 
anaerobic bacteria) involved in the process. 
1.7 Medical implant coatings 
Coatings have been utilised since ancient times for various purposes. The interest of 
the author is directed towards the field of orthopaedics and bone implants in general. 
The use for orthopaedic device coatings was initiated by an ever increasing problem 
of failing bone implants. The main purpose for an invasive surgery and employment 
of a device is to restore and improve a potentially morbid function of bone which in 
turn would allow fast rehabilitation and bone healing. However, while an appropriate 
mechanical and biological function is ideal, acute and chronic infections provide 
complications that might lead to further invasive surgery (Moriarty et al., 2010, 
Darouiche, 2004). Coatings for bone prosthesis are predominantly designed to 
enhance osseointegration; however there is always a competition between host cells 
and microorganisms to adhere onto the surface, a phrase named “race for the 
surface”(Gristina, 1987). These coatings can be categorised into two distinct groups: 
Table 1 - A series of bacterial species involved in dental related infections. Bacterial population 
percentages compare infection occurrences when healthy implants are compared to failing implants. The 
population of most species increase significantly during peri-implantitis. Data obtained from Persson et al 
(Persson and Renvert, 2014).   
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passive or active. Passive coatings are referred to as coatings that are not able to 
release any bactericidal agents into their immediate surroundings; an example of this 
is hydroxyapatite coated materials. Active coatings on the other hand are coatings 
that mitigate bacterial adhesion or are actively releasing bactericidal agents 
(Goodman et al., 2013).   Aside from understanding the biology and structure of the 
bone, it is required to understand and study other bone-related factors involved in 
developing relevant bone prosthesis. These involve the coating materials used, 
design of the implant, its various methods of fixation and ultimately its shape. The 
following is a brief outline of two coating materials utilised in the current study and 
their relative advantage and disadvantages.  
 
1.7.1 Hydroxyapatite as a coating material 
 
Natural hydroxyapatite (HA) constitutes nearly 65% of the bone. Its relatively simple 
chemical composition Ca10(PO4)6(OH)2, has allowed scientists to successfully 
reproduce it under laboratory conditions. Investigators have since used numerous 
ways to incorporate this ceramic into bone studies, often by using it as filler for bone 
(Sotome et al., 2004). In the fields of medicine and dentistry, calcium phosphates 
have gained substantial attention and most of the medical devices that are in contact 
with bone are coated with a layer of calcium phosphate. This is because of its innate 
ability to allow bone growth, in other words, hydroxyapatite is a biocompatible 
osteoconductive material (Chu et al., 2002). Osteoblasts found in the structure of 
trabecular bone interact well with it and can proliferate inside its porous structure. 
There are however disadvantages. One of the most important factors is its brittleness. 
Using HA on medical implants that require intense surface torsion or impact pressure 
can prove difficult. Other problems include an incompatible Young’s modulus to that 
of  the bone and not being able to resist tension or shear (Mahan and Carey, 1999). 
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These properties however do not take away the fact that, today, nearly all titanium 
based orthopaedic related devices use HA as a coating that acts as a bone substitute 
to promote bone growth and oseoinduction. Titanium metal has been frequently used 
for medical purposes (Figure 4).  
Its applications in the field of 
orthopaedics are many; this is 
because of the unique set of 
properties that this metal offers. 
Early animal experiments in the 
1940s indicated its 
biocompatibility and its use in the 
medical field has continued since 
(Wang, 1996). In general, a bone 
implant should have the same 
mechanical properties as the bone 
itself. Finding this property in 
inorganic materials can be a 
challenge and scientists have not 
been able to achieve this ideal. 
Titanium also does not does not 
have the “required” properties as a 
bone implant. It has a higher 
modulus compared to that of the bone, meaning it is not as elastic. 
 
 
Figure 4 – Human femoral titanium prosthesis. A) 
Cancellous bone, the metabolically part of femur B) 
Cortical bone has a strong and dense structure that is 
in full contact with the external site of the 
prosthesis. The black arrows represent the sites 
where the implant is in full contact with bone. This 
particular implant is not coated and is semi-external.  
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This causes the bone to lose its mass due to the stress shielding and load imbalance.  
Due to these factors and various other complications, the introduction of HA to the 
surface of titanium implants is a necessary addition. It is has to be stressed that that 
surface structure of such implants also present a profound effect on how these 
implants behave mechanically. In order to address this issue scientists have utilised a 
rough titanium surface that possesses porous structures so that bone ingrowth at the 
later stages of implantations is as  mechanically stable and secure as possible 
(Morscher, 1991, Giordano et al., 2004). 
 
1.7.2 Nanoparticles as coating materials 
 
 
NPs generally refer to materials that are smaller than 100 nm. Their importance and 
usage in the field of biology and medicine are widespread (Salata, 2004). Their small 
size makes them particularly notable to science and modern medicine. This property 
has allowed innovative methods to be devised by scientists in the field of nano-
medicine. A  notable example of this is the usage of silver NPs for antimicrobial 
purposes (Morones et al., 2005). Many more materials such as polymers 
(encapsulated with drugs) can also be turned into NPs via different methods. These 
nanoparticulates can travel almost “freely” within a biological system and have been 
found to be useful in the fields of cancer therapy (Yang et al., 1999, Ferrari, 2005). 
Some NPs are able to target cancer cells and others can be traced in vivo using 
modern medical imaging techniques. Scientists have been able to use these particles 
as “magic bullets” to target a specific tumour (Jordan et al., 1999, Jain et al., 2007).   
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The concept of magic bullet refers to “selectivity” in drugs. This can mutually apply 
to the field of NPs. Some nanoparticulates may be coated with different materials so 
that their surface is recognised by the cells of interest, thereby attaching to the 
surface of the microorganism and causing damage, while in other NPs, coating is not 
necessary and the same type of behaviour can be achieved using particulates that are 
able to show selectivity towards different bacterial species  (without being 
manipulated chemically) as well as diverse type of cancer cell lines (Reddy et al., 
2007, Ostrovsky et al., 2009). Furthermore, it has been observed that as the size of 
NPs decrease, their antimicrobial activity increases, therefore relating the bactericidal 
effects to shape, most nanoparticles have different shapes based on the different 
methods with which they were synthesised (Choi and Hu, 2008, Azam et al., 2012). 
This is an important feature that could prove useful in future investigations of this 
field and is also explored in our present study. NPs are however not without their 
side effects and can accumulate in certain organs or tissues in order possibly cause 
biological toxicity (Tang et al., 2009). Therefore if nano-sized particles are to be 
implemented as coating materials for medical devices, they need to be secured onto a 
surface, this could be achieved both mechanically as well as chemically, using 
various innovative methods (i.e plasma spray or EHDA). 
1.8 Coating systems  
The last generation of orthopaedic implants did not have the capacity to be bioactive 
or introduce bone growth around the device. This is because the prosthesis was 
surrounded by cement that was not bioactive. This provides an interface between 
bone and the implant, preventing any direct contact between the two, leading to an 
end-result that  seems to be satisfactory (Huo and Osier, 2008). However, because of 
catastrophic events of post-operative failure in cemented implants such a huge bone 
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loss and free debris of cement in the structure of the bone (Hungerford and Jones, 
1988, Navarro et al., 2008), scientists have been searching for more bioactive and 
biocompatible methods that could be applied to both orthopaedic and dental 
implants. Uncemented implants are the product of this pursuit. These are products 
that with the help of modern technology have been coated with osteoconductive (i.e 
being able to attract bone material such as hydroxyapatite to provide the needed 
stability). Some post-operative results indicate that these uncemented implants could 
prove as effective as their cemented counterparts (Hofmann et al., 2002).  Most 
uncemented implants in the field of orthopaedics use thermal coating methods such 
as plasma spraying that allow the attachment of deposited materials by using very 
high temperatures of around 20,000 ºC (Zaat, 1983). The use of such temperatures 
can lead to rapid deterioration of the plasma gun and prove very expensive. Other  
methods such as ultrasonic nozzle and electrohydrodynamic atomisation (EHDA) 
provides a novel method for coating medical devices that cost much less than the 
thermal methods and provide an equally uniform and efficient coating (Huang et al., 
2011).  Finally, regardless of coated and uncoated devices, there is an urgent need for 
major reform in the field of biomaterials and antimicrobials. Multiple examples for 
such novel coatings are the incorporation biomolecules, such as antimicrobial 
peptides which might lead to bone/implant integration by having desirable effects on 
cell function and differentiation (Goodman et al., 2013). Furthermore, layer-based 
coatings, whereby between each layer of a multi-layered coating there are active 
molecules that are released in a controlled manner, the sustained release of active 
agents could prove beneficial for long term maintenance of the implant-bone 
interface (Sun and Lynn, 2010).  Technologies and scientific discoveries are an ever 
evolving phenomena, this evolution also applies to living beings such as bacteria. As 
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a species, humans need to comprehend and expand their relevant knowledge in order 
to tackle the ever increasing challenge of antimicrobial resistance and colonisation. 
This requires innovative new approaches which allow benefits and challenges these 
ever adapting threats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 
Hypothesis 
 
A nano-based coating system will offer enhanced antimicrobial activity 
for future bone-related implants. This coating will also allow for 
efficient, bio-functional and stronger bone integration.  
 
 
Aims and Objectives  
 
 To understand, compare and analyse the antimicrobial capability 
of a number of novel nanomaterials for potential future medical 
use. 
 To provide mechanistic evidence as to how nZnO is able to 
instigate its antimicrobial effect. 
 To optimise a novel nano-based coating system in order to create a 
thin but functional surface that is both biocompatible and 
potentially osteoconductive. 
 To compare and contrast novel coatings with conventional 
dental/orthopaedic coatings. 
 To innovate and bring new ideas as to how manipulation of 
coating surfaces can maximise implant stability and performance.  
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Chapter 2  
  
Investigations into the antimicrobial activity of nano-metal 
oxides. 
 
1. Introduction 
 
1.1 Emergence of antibiotic resistance  
Exploited by humans since the discovery of penicillin, the resistance to antibiotics is 
the major factor behind the ultimate failure of an ever continuing struggle against 
bacterial pathogens (Davies and Davies, 2010). 
The human body is colonised by approximately 1014 bacteria, this is despite the fact 
that our bodies are roughly comprised of 1013 eukaryotic cells (Clemente et al., 
2012). Our microbiome is at the centre of major scientific research efforts and as a 
result we are getting ever closer to an understanding of the important role that 
bacteria play in our everyday lives. It is therefore vital to understand that these 
microorganisms live in symbiosis within and on our bodies and also are an important 
part of human evolution (Xu et al., 2007). Since there is no single species of bacteria 
within our bodies, there is a struggle and symbiont relationships between the pre-
existing bacterial species in this dynamic environment (Dethlefsen et al., 2007). This 
interspecies mutualism can be disrupted if a small population of antibiotic resistant 
bacteria are introduced to a region where no pre-existing host population is present. 
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Despite exposure to antibiotics, the newly introduced bacteria are likely to thrive, 
proliferate and eventually become established elsewhere in the body.  
Some bacteria are naturally resistant to antibiotics and as the newly introduced 
population increase in numbers, mutations occur leading to the development of 
bacteria with lower susceptibility to applied drugs (Wang et al., 1998). There are 
multiple ways in which resistance can occur, namely, mutation, protection, 
replacement and alteration of the drug target or mechanisms that involve inactivation 
or removal of the drug (Canton, 2009). The unsupervised global experiment in 
bacterial evolution (Figure 5) is therefore a direct link to the accelerated process of 
antimicrobial resistance.  This is an ill-fated situation since not only do bacteria 
possess the strongest total number of species on our planet but they are vastly 
diverse. Not much is known about fundamental bases for antimicrobial resistance. 
The ecology and role of resistance genes are still new to science, our limited 
knowledge as to how bacteria thrive in its natural environment is still in its infancy 
and despite this limited knowledge, some species of bacteria contain antibiotic 
resistance genes despite human intervention (Allen et al., 2010).  In fact, Alexander 
Fleming who discovered penicillin in 1928, had warned that bacteria could evolve to 
beat antibiotics and a recent report by the World Health Organisation (WHO) 
published on April 30th, 2014 confirms this prediction. Therefore we are fighting a 
losing battle. However a strategy of prevention, rather than total obliteration is the 
most appropriate solution.  
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1.2 Infections and a new generation of antimicrobials 
The following section will focus on important and relevant pathogens to the current 
study and subsequently introduce novel ways that can be applied in order to decrease 
the probability of infections or contaminations.     
Gram positive infections make up the majority of bone and joint infections (Darley 
and MacGowan, 2004).  With regard to bone and specifically joint related 
procedures, conventional antibiotics are thought to only penetrate into the peripheral 
regions and fail to gain access to deeper regions of bone. As a result, treatment of 
osteomyelitis and joint related infections requires prolonged periods of time to take 
effect (Del Pozo and Patel, 2009). Consideration of such factors and the role of 
bacteria in the more common bone related infections has placed an emphasis on the 
following species: 
 E. coli 
 P. aeruginosa  
 S. epidermidis 
 S. aureus 
 
 Figure 5 - Evolution through the process of natural selection is the major drive behind the phenomena of bacterial 
resistance.  Image adopted from www.Science.com and http://academy.asm.org. 
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1.2.1 Escherichia coli (E. coli) 
E. coli, a gram-negative species, and a facultative organism, is one of the species of 
bacteria that humans are exposed to early in life. E. coli can colonise the gut and is 
one the main members of the faecal bacteria (Edberg et al., 2000). Any object 
touched or in direct contact with our skin would almost certainly be contaminated 
with faecal bacterial populations that include E. coli. When presented into and on 
tissues that are not normally inhabited by such bacteria, pathogenesis can occur.  E. 
coli contamination that may lead to bone loss is rare but can occur in multiple ways 
such as an open fracture or contamination via soil faecal material. Moreover, E. coli 
related osteomyelitis can similarly occur in the very young and elderly patients and 
often occurs in their long bones. A case reporting a rare maxillofacial E. coli 
infection indicates that, after consumption of contaminated water, bacteria had found 
their way into the bone tissue, causing serious bone loss (Padhiary et al., 2013). It has 
also been observed that conventional antibiotics utilised by dentists are often 
impractical and further care and of multiple antibiotics courses are required in order 
to deal with these types of infections. Researchers reporting these findings stress that 
while rare, most surgeons would benefit if E. coli was always considered as a 
potential candidate for aggressive osteomyelitis (Padhiary et al., 2013). 
1.2.2 Pseudomonas aeruginosa (P. aeruginosa) 
This species is involved mainly with contamination that occurs within catheters and 
various foreign body implants. P. aeruginosa is gram negative and not commonly 
associated with bone related diseases. However, P. aeruginosa is the predominant 
species removed from contaminated bone implants. A recent study also suggests that 
biofilm formation by this species can have detrimental effects as initial antibiotic 
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treatment decreases the population by 44%, however the remaining resistant cells are 
no longer treatable by conventional antibiotics anymore (Daniëlle et al., 2005). 
Furthermore orthopaedic prosthesis that are contaminated by this species of bacteria 
are often required to be subjected to multiple medical revisions, solely for the nature 
of the infection, often needing the application of multiple antibiotics at the same 
instant (Bernard et al., 2004).  
 
1.2.3 Staphylococcus epidermidis (S. epidermidis)  
S. epidermidis is a gram positive species found on the surface of the body, mostly 
skin (Grice and Segre, 2011). It is predominantly related to nosocomial infections 
and therefore is a high risk to patients who undergo invasive surgical procedures. 
With respect to bone and medical devices, the implants presented by surgeons are 
sterilised but contamination can occur if there is minimal contact between the 
patient’s skin and the medical device. Therefore, S. epidermidis can be transferred to 
bone and produce a rather thick multi-layered biofilm. Similar to most bacteria, 
biofilms are thought to protect S. epidermidis from the host’s defence system and 
potential antibiotics applied to the infected area (Lima et al., 2013). Furthermore, S. 
epidermidis can release lantibiotics, a group of antimicrobial peptides which serve as 
a deterrent for other gram-positive species in addition to providing exclusivity for 
this species to grow on a surface without competition (Harris and Richards, 2006), 
leading to biofilm formation.   
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1.2.4 Staphylococcus aureus (S. aureus)  
S. aureus is responsible for most biofilms formed by a single species of bacteria in 
bone related diseases. Studies investigating this bacteria indicate that contamination 
and biofilm formation are the main reason behind chronic osteomyelitis (Marrie and 
Costerton, 1985). This chronic disease destroys bone and in parallel osteogenesis 
markers dramatically decline over time. An in vitro study, over a period of 7, 14 and 
21 days measured the production of one of these markers to see if there is a direct 
relationship between S. aureus infection and bone-marker reduction. Comparison 
between infected and uninfected osteoblast cultures incubated for more than 21 days 
indicated a significant reduction in  bone marker production in infected cells (Widaa 
et al., 2012). S. aureus also has other properties such as the heightened ability to 
adhere to the surfaces of biomaterials that are exposed to plasma proteins.  When 
introduced into the bone via the route of an implant, by utilising adhesins that are 
termed   microbial   surface   components   recognizing   adhesive matrix molecules 
(MSCRAMMs), bacteria can adhere to regions (Patti et al., 1994) that are essential 
for bone formation and will inhibit their function. 
1.3 An alternative to traditional antibiotics  
Because of the continued failure of antibiotics and the rise of resistant strains of 
bacteria mentioned in the previous sections (Section 1.1), NPs offer new 
opportunities as potential precautionary antimicrobial agents. Unlike conventional 
antibiotics, they are believed to instigate their effects via multiple mechanisms that 
are discussed further in this chapter.  Their varied and yet almost homogenous size 
coupled with their heterogeneous structures gives them the ability to show enhanced 
antimicrobial activity against most pathogenic bacteria. These synthesised NPs are 
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Figure 6 - An outline of the specific setup for the 
flame pyrolysis method. The fuel and the 
precursor for the NPs are fed through the nozzle. 
The mixture is then synthesised using spray flame 
which is controlled by the intensity of fuel 
injection and hence directly affecting the NP 
production. Image obtained from Mueller et al, 
(2003) with permission. 
also multifunctional. They are utilised as coating materials on clothes, food storage, 
cosmetics and sometimes for diagnostic and medical applications that are directly 
invasive (Park et al., 2009, del Campo et al., 2005). Understanding the full scope of 
their potential within different disciplines of the sciences, especially that of medical 
science, can result in novel innovations that will potentially lead to an increase in the 
longevity of human life. In the present study, nanoparticulates in suspension as well 
as on coated substrates are exposed to different environmental circumstances 
hypothesised to influence their antimicrobial behaviour. The resulting activity should 
provide a great deal of insight into how bacteria react when exposed to environments 
dominated by these small scaled particulates.  
2 .Materials and Methods 
 
2.1 Nanoparticles  
 
All NPs except nHA were synthesised 
using the unique method of flame 
pyrolysis (Figure 6). The basic 
method is initialised when the 
precursor of the NPs is mixed with 
fuel (usually ethanol) and passed 
through a nozzle that leads to a spray 
flame which in turn aids synthesising 
these particulates based upon its 
height and intensity. The synthesised 
particulates are then collected in a 
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collector and processed. The advantage of this system is in its relative simplicity as 
well as the broad spectrum of nanoparticulate precursors that can result in various 
functional NPs upon successful synthesis (Mueller et al., 2003).  
The metal oxide NPs are therefore well characterised with an increased surface area 
to weight ratio and a size range of between 50 and100 nm. Handling and storage of 
these NPs was carried out according to industrial safe-working practices to avoid 
biological and environmental harm. The NPs were not discarded into the sewage 
system; they were instead filtered and incinerated. The NPs tested included: Zinc 
Oxide (nZnO), Titanium Dioxide (nTiO2), Tungsten Oxide (nWO3), Cupric Oxide 
(nCuO), 70% Silver + Zinc Oxide (70% wt nAg + 30% nZnO), 70% Silver + Cupric 
oxide (70% wt nAg + 30% nCuO) and Hydroxyapatite (nHA). Hydroxyapatite NPs 
were made by the process of wet precipitation between calcium hydroxide (Ca(OH)2) 
and orthophosphoric (H3PO4) acid.  
Collectively, most NPs were suspended in 100% ethanol and were sonicated for a 
period of 5 min thoroughly in order to maintain particulate stability. The exact 
mechanism with which the mixed NPs were created was not disclosed by the 
Johnson Matthey plc. Selection of these NPs depended upon their availability, 
scientific relevance, novelty and their potential applications based upon previous 
findings.  
2.2 Bacteria 
Both gram negative and gram positive species of bacteria were used in the present 
investigation. These included: Staphylococcus aureus (Oxford, NCTC 6571), 
Escherichia coli (NCTC 9001), Staphylococcus epidermidis (Lab Isolate) and 
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Pseudomonas aeruginosa (PAO1). All of these species are known to be involved in 
orthopaedic and bone related infections.  
2.3 Minimum bactericidal concentration (MBC) 
 
Minimum bactericidal concentration determination indicates the lowest concentration 
of an antimicrobial agent / antibiotic that can kill all bacteria in a given setting. 
Bacteria obtained from frozen stocks were grown on TSA (Tryptone Soya Agar – 
Oxoid, UK) plates for a period of 24 h at 37ºC in a 10% CO2 Incubator. 3 to 4 
colonies were removed from the plate and mixed in 5 mL of TSB (Tryptone Soya 
Broth - Oxoid, UK) in a 20 mL universal tube (sterile conditions).  
Bacterial suspensions were placed in a shaking incubator at 200 rpm for a period of 
24 h under at 37°C. The optical density (O.D.) of the turbid suspension was adjusted 
to 0.1 at a wavelength of 540 nm (this corresponds to a population of ~106 bacteria). 
A volume of 1 mL from NP concentrations tested (250, 500, 1000 and 2500 µg/mL) 
was added to a series of 1.5 mL centrifuge tubes and subsequently inoculated with 
12.5 µL of bacterial culture with the inclusion of positive and negative controls. The 
positive control consisted of 1 mL of TSB inoculated with 12.5 µL of the bacteria, 
while the negative control was 1 mL of TSB. A volume of 5 µL from each of these 
mixtures was taken and inoculated onto a plate immediately and left in an incubator 
overnight at 37ºC, 10% CO2. 
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2.3.1 Comparative agar based MBC determinations 
Multiple concentrations of nanoparticulate suspensions mixed in 1.5 mL tubes were 
left in a shaking incubator at 200 rpm, 37ºC and 10% CO2. The NPs used were 
comprised of nWO3, nZnO, and nAg 70% wt + 30% nZnO. The tubes were removed 
from the incubator and left in room temperature for 10 min. This allowed for 
precipitation of nanoparticulates and therefore the total removal of bacteria. An 
aliquot of 50 µL was removed from each bacterial/NP suspensions and placed on a 
TSA plate and placed at 37ºC, 10% CO2 overnight. Bacterial growth was 
qualitatively analysed and compared for each suspension (Figure 10). 
 
2.4 Minimum inhibitory concentration (MIC) 
 
Bacteria were obtained from frozen stocks, thawed and plated onto TSA plates for a 
period of 24 h to allow sufficient growth. The freshly grown bacteria were removed 
from the plate and were mixed in 5 mL of TSB in a universal tube. The bacterial 
suspension along with 5 mL of broth (control) was placed in a shaking incubator for 
a period of 24 h. The O.D. of the turbid suspension was adjusted to 0.1 at the 
wavelength of 540 nm using a light spectrometer. Furthermore 1 mL of each NP 
concentrations was added to a series of 1.5 mL tubes and subsequently inoculated 
with 12.5 µL of the bacterial suspension. A 200 µL sample from each of these 
mixtures was obtained and placed in a 96 well plate and the initial O.D. was 
measured using a plate reader. The tubes were then placed in a shaking incubator 
(100 rpm) for a period of 24 h and a 200 µL sample removed and the final O.D. 
measured. 
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2.5 Time based bactericidal studies 
 
Concentrations of NPs were suspended in PBS and ABS.  Concentrations from 250 
µg/mL to 2500 µg/mL were used to observe their bactericidal properties. The 
suspensions were sonicated for 5 min. Subsequently 450 µL of each suspension was 
re-suspended into 1.5 mL micro-centrifuge tubes. In addition, 50 µL of the O.D. 
adjusted bacterial suspension (only S. aureus and E. coli) were introduced into these 
tubes and a 1:10 serial dilution was performed for each nanoparticulate suspension. 
Furthermore 20 µL of each mixture was plated on TSA plates and incubated 
overnight at 37°C, 10% CO2. Colony forming units (CFU/mL) were then counted 
and the number of bacteria present in each mixture was quantified and calculated. S. 
aureus and E. coli were chosen as representatives of gram positive and gram 
negative bacteria. 
                                                   2.6 Coating with NPs 
2.6.1 EHDA deposition of NP coating 
EHDA was used to coat all samples (Figure 7). This is a relatively novel and cheap 
method that allows for the formation of a uniform coating onto the surface of 
samples with high productivity and versatility. Briefly, EHDA consists of an epoxy 
resin embedded nozzle connected to both a power supply (Glassman High Voltage, 
Inc) and a 10 cc syringe pump (Harvard Apparatus, PHD 4400 Programmable) 
containing suspended NPs. The applied voltage (3.2 - 4.2 kV) creates an electrical 
field between the nozzle and the substrate, which allows for the formation of a 
uniquely shaped stable cone jet. Such a jet, together with a steady flow rate of 5 
µL/min, is required to create a uniform spray which forms nano sized droplets that 
encapsulate the NPs. The spraying is carried out for 2 min with a 30 mm distance 
53 
 
between the tip of the nozzle and the substrate. Subsequently, the coated samples 
were heat treated at 500ºC for 1 h and allowed to cool gradually to help ensure the 
stability of the coating, allowing for mechanical integrity of the adhered NPs. The 
spraying time was defined based upon crack-formation on these surfaces. This was 
tested by looking for potential surface coating cracks using electron microscopy. The 
2 min coating period produced a thin layer of coated NPs with no cracks. 
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Figure 7 - Electrohydrodynamic deposition schematic illustration. From left to right: Syringe 
Pump, power supply to generate the electrical field between the needle and the Syringe filled 
with nanoparticles suspended in ethanol, ground connection for avoiding an electrical shock, the 
glass/metal sample (situated on top) and the substrate, nozzle and spraying process, Light 
source is also incorporated to provide a better visualisation of the spray.   
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2.6.2 Glass substrates 
 
Glass slides and 13 mm coverslips were used in this study (VWR international). 
These slides were utilised for most studies whereas 13 mm circular glass coverslips 
(agar scientific, UK) were used for studies involving immunostaining.  A diamond 
cutter pen was used to separate 1 cm2 samples from each glass slide. In order to 
create sterilised substrates, each sample was dipped in 70% ethanol for a period of 1 
min and air dried for 5 min before EHDA spraying. Various concentrations of 
nanoparticulate suspensions and nHA (in 100% ethanol) were made by calculating 
the nHA/NP ratio (1:1) and sonication before spraying. These concentrations ranged 
from 500 – 10,000 µg/mL for both NPs.   
  
2.7 Nano-coated bactericidal samples 
The spraying was carried out for 2 min with a fixed 30 mm distance between the tip 
of the nozzle and the substrate. Subsequently, the coated glass samples were heat 
treated at 500ºC (250ºC was used for 13 mm samples as they have a brittle nature 
and cannot survive higher temperatures) for 1 h and subsequently cooled in a gradual 
manner in order to ensure the mechanical integrity of the coating. 
 
 2.7.1 Bactericidal testing: samples in bacterial suspensions 
 
The glass samples were coated with both nZnO and nWO3 for periods of 2, 4, 6 and 
8 min at 10,000 µg/mL. These were then sterilised using 70% ethanol placed in 3 mL 
volumes of PBS together with 37.5 μL of O.D. adjusted (0.1 at 54 nm, which equates 
to 106 CFU/mL) bacterial suspension (S. aureus). Samples were placed in a shaking 
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incubator at 37°C for 24 h. Dilutions of the suspensions (1:10) were performed, agar 
plates inoculated and colonies counted after overnight incubation at 37ºC in 10% 
CO2.  
2.7.2 Bactericidal testing: Bacterial suspensions on samples 
 
The coated samples were dipped in 70% ethanol for 1 min and flamed to ensure 
sterility. Test species of bacteria were grown overnight in TSB at 37°C and 200 rpm. 
The O.D. of the bacterial suspension was adjusted to 0.1 at 540 nm in PBS or ABS 
(106 CFU/mL). A volume of 30 µL of the O.D. adjusted bacteria suspension was 
transferred onto the surface of the coated samples. As 30 µL is an extremely small 
volume of liquid, initial experiments displayed that once placed in an incubator; the 
liquid evaporates after only a few hours of incubation. Therefore a method was 
devised whereby a dampened cloth was placed next to the samples in order to create 
a humidified chamber. The samples were then placed in an incubator at 37ºC with 
10% CO2 for a period of 24 h. Subsequently each sample was carefully removed and 
placed in 3 mL of PBS. Approximately 5 glass beads were added to each tube to aid 
the detachment of the bacteria while vortexing (non-detrimental to bacteria) the tubes 
for a period of 30s at 2500 rpm. A volume 50 µL of the suspension was then 
removed and a 1:10 serial dilution performed.  Neat (not diluted) and dilutions (1:10) 
were plated onto TSA plates and incubated for 24 h at 37ºC, 10% CO2, after which 
colonies were counted. 
 
 
 
57 
 
2.7.3 Bactericidal testing: patterned coated samples 
Custom made grids (agar scientific – 3.0 mm) with various internal patterned shapes 
were used in order to create diverse structural patterns. These patterns can be made 
on any surface and their thickness controlled by the timing and height of the coating 
process. The coating times for the present coatings were 2 and 5 min respectively. 
The 2 min coating time was used for antimicrobial tests and because visualising NPs 
is challenging under an optical microscope, the 5 min coating time was chosen. Each 
grid was carefully attached to a square shaped paper plate (1 cm2) with four girds 
positioned at each of it extremities. The paper plate was positioned on top of the 
glass substrates. The regions covered by the grids would be coated and the rest 
remain uncoated.  
2.8 NP characterisation 
 
ZnO NPs were placed in 5 mL of distilled water and sonicated (Diagenode, 
Bioruptor) for 30s intervals at a high frequency setting in order to provide an even 
suspension. Carbon film grids (400 Mesh Cu, Agar Scientific) were briefly dipped 
into the nanoparticulate suspension and left at room temperature to air dry. This 
process allows for the NPs to be trapped within these grids and remain there for 
extended periods of time. The prepared grids were transferred into the Transmission 
Electron Microscope (TEM) through a vacuum chamber and each sample viewed and 
analysed.  
2.9 Statistical analysis 
One way ANOVA and student’s t-Test (GraphPad Prism 5) were used to analyse all 
data and time-point comparisons. When p < 0.05, the analysis was considered 
statistically significant.  
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3. Results 
3.1 Nanoparticulate characterisation 
 
Synthesised NPs have various shapes and structures. Figure 8 highlights these unique 
structural characteristics for multiple NPs that were tested for their potential 
antimicrobial activity in the present study. Because NP size and shape are believed to  
be an important factor in instigating their antimicrobial activity (Sotiriou and 
Pratsinis, 2010), it is likely that these characteristics could also lead to their 
multifunctionality as antimicrobials targeting multiple microbial sites.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 - Electron micrograph of numerous NPs. A) ) Zinc Oxide (nZnO), B) tungsten oxide 
(nWO3), C) nAg conjugated nZnO particulates and D) nAg conjugated nCuO particulates. The 
average sizes for all nanoparticulates are between 20 – 100 nm.  
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Initial observations indicate that the two mixtures of 70% nAg + 30% nZnO and 70% 
nAg + 30% nCuO were collectively comprised of bulky circular structures that were 
surrounded with smaller particles that are chemically attached to the larger particles. 
The sizes of the larger agglomerated regions were approximately equal to one 
another, whereas the smaller particles varied in size. For the 70% nAg + 30% nZnO 
particulates, the average size for the nAg agglomerations was 75 nm and the nZnO 
particles were between 10 and 50 nm. The second mixture that comprised of 70% 
nAg + 30% nCuO demonstrated altered features with agglomerated regions varying 
greatly in size (between 50 - 100 nm) and smaller copper oxide NPs measuring 
between 10-50 nm. The physical contrast between NPs is more transparent when 
both nZnO and nWO3 are compared to one another. 
While similarities exist between their sizes (on average between 20 – 100 nm), their 
structures are different. Whereas nWO3 comprises of particles that possess a round 
shape, nZnO particles have rod-like and elongated structures that have sharp edges. 
This is further highlighted in Figure 9, where a comparison between nZnO and nTiO2 
is showcased. The nTiO2 possess round shapes, similar in size to nZnO but lack 
sharp edged confirmations. Red triangles indicate round shaped TiO2 particulates. 
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3.2 Antimicrobial studies 
3.2.1 Minimum inhibitory (MIC) studies 
 
Inhibitory concentrations of NPs indicate an overall antimicrobial superiority of the 
conjugated nanoparticulates. MIC values against all species of bacteria were 
comparatively high (> 500 µg/mL) with the exception of the chemically modified 
mixtures of nAg and nCuO. Cupric oxide NPs demonstrated an increased inhibitory 
activity towards most bacterial species closely followed by the zinc oxide NPs (Table 
2). The tungsten oxide NPs demonstrated their bactericidal effects at 2500 µg/mL, 
the highest concentration of NPs used in this experiment.   
 
 
 
Figure 9 - Transmission electron micrograph of both ZnO (A) and TiO2 (B) nanoparticles. A)  Red lines 
indicate rod shaped structures of the NPs whereas the black triangles showcase the sharp edged particles. B) 
TiO2 NPs are similar in size but lack sharp edged confirmations. Red triangles indicate round shaped TiO2 
particulates (Memarzadeh et al, 2014). 
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3.2.2 Minimum bactericidal (MBC) studies  
Similar patterns were observed when the MBC for each NP was determined with the 
composites having the greatest bactericidal effect. As with other antimicrobial agents 
the concentration required to kill is generally found to be greater than that required to 
inhibit growth (Table 2).  
These findings indicate that there was no underlying specific selectivity towards any 
of the two gram-negative (E. coli & P. aeruginosa) and gram-positive (S. aureus & 
S. epidermidis) by any of the NPs presented in this study.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 - Minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC) values (µg/mL) for nZnO, nCuO, nWO3, as well as novel mixtures of nAg with nCuO 
and nZnO against four different species of bacteria. Nano-TiO2 is thought to be antimicrobial 
when exposed to ultraviolet light and therefore not used in this experiment.  
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3.2.3 Agar-based bactericidal study 
For comparative purposes, S. aureus and E. coli were used in this experiment. 
Qualitative assessments of the drop-based bactericidal studies indicate that all 
positive controls exhibited full growth and all negative controls exhibited no growth. 
Results for both nZnO and the nAg, nZnO composite indicated bactericidal activity 
for all applied concentrations (250, 500, 1000 and 2500 µg/mL) against both tested 
species of bacteria. Contrary to these findings, nWO3 did not show any bactericidal 
activity against E. coli and S. aureus. It is important to note that despite this total 
growth, when exposed to 2500 µg/mL, the bacterial growth was not as prominent as 
compared to preceding concentrations and instead of forming regions of growth that 
are approximately 0.5 cm in diameter, there were clusters of individual colonies 
forming on the plate (Figure 10). 
3.2.4 Optimisation of time based bactericidal assays  
An initial test to observe the bactericidal efficiency of specific nanoparticulates 
within a given time period and a given environment was devised. 70%nAg + 30 % 
nZnO was tested against both S. aureus and E. coli (Figure 11 and 12) respectively. 
Apart from the significant (p < 0.01) antimicrobial activity of this nanoparticulate 
against both species, these findings allowed for further investigation of the current 
method. As regards to the antimicrobial activity of this novel mixture, there was a 
strong antimicrobial activity against both bacteria after the second hour of 
incubation. This was more evident for the bactericidal effect of this mixture against 
S. aureus (Figure 11). 
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Figure 10 - Comparison of the bactericidal activity of tungsten oxide (nWO3), Zinc oxide (nZnO) and nZnO 
mixed with nAg (70% nAg + 30% nZnO).  Various concentrations of NPs were exposed to an O.D adjusted 
suspension of bacteria (S. aureus or E. coli) and cultured on TSA plates for comparative purposes. Bacteria 
containing supernatants for all concentrations of NPs (250 µg/mL, 500 µg/mL, 1000 µg/mL and 2500 
µg/mL) were placed on TSA plates. Their growth was compared to the negative (no bacterial growth) and 
positive (total bacterial growth) control. TSA plates were placed at 37°C with 10% CO2.  
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Figure 11 - The bactericidal activity of 70% nAg + 30% nZnO in PBS against S. 
aureus. The concentrations of NPs were exposed to suspended bacteria in PBS 
for 1, 2, 3 and 4 hours. All percentages are compared to the control. n = 3, 
±SEM, ** = p < 0.01 
Figure 12 - The antimicrobial activity of 70% nAg + 30 %nZnO in PBS against 
E.coli. There is a significant reduction in bacterial survival after exposure to all 
concentrations of NPs. n =3, ±SEM, * = p < 0.05.  
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Because of an observed bactericidal effect of nWO3 (MIC = 2500 µg/mL) in the 
initial MIC and MBC investigations, the need to further investigate the antimicrobial 
potential of nWO3 was investigated. The rationale behind carrying out a time based 
antimicrobial study was to further investigate selected nanoparticulates for their 
antimicrobial activity, before selection and their application onto a coated substrate. 
At the time of writing this work, of all tested NPs, both nWO3 and nZnO were 
significantly less studied as compared with other commercially available NPs such as 
silver and copper. Further investigations into the bactericidal of nWO3 showed that 
all concentrations of this nanoparticulate tested were seldom bactericidal in timed-
based killing assays, over a period of 4 h, confirming the previous finding and 
contradicting the initial results obtained in the MIC and MBC investigations which 
showed antimicrobial activity at 2500 µg/mL. As the NPs in suspension were 
exposed to both S. aureus and E. coli, no significant change was observed at each 
hour (Figures 13 and 14). ZnO NPs were selected as the most effective antimicrobial 
agent in the current setting of experiments. Nano-Ag has been used for multiple 
purposes in many fields and so was not investigated further, the over-use of silver 
can lead to future antimicrobial resistance (Silver, 2003, Percival et al., 2005). 
Furthermore, CuO is widely known to be toxic to human cells (Karlsson et al., 2008, 
Hanagata et al., 2011) and nTiO2 is not a strong antimicrobial agent (Figure 15) and 
only antimicrobial under certain conditions(Brunet et al., 2009). After validating the 
physical characteristics and elemental composition of nZnO powder (Figure 16), 
both E. coli and S. aureus were exposed to suspension of nZnO particles under 
different nutritional environments. These species were chosen because of their ever 
increasing importance as the main emerging pathogens with respect to health-related 
infections.  
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Figure 13 - The effect of different concentrations (µg/mL) of nWO3 against S. 
aureus suspended in phosphate buffered saline. The antimicrobial activity was 
observed at each successive hour for a period of 4 hours. n =3, ±SEM 
Figure 14 - The effect of different concentrations (µg/mL) of nWO3 against E. 
coli suspended in phosphate buffered saline. Limited antimicrobial activity was 
observed at each successive hour for a period of 4 hours. n = 3, ±SEM 
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Figure 15 - The effect of different concentrations (µg/mL) of nTiO2 against S. aureus 
and E. coli suspended in PBS. Limited or no antimicrobial activity was observed at 
each successive time period for a period of 4 hours. n = 3, ±SEM 
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Figure 16 - The nZnO powder was tested for its purity by utilising EDX (Energy-dispersive 
X-ray spectroscopy) via scanning electron microscopy. The spectrum indicates the purity, 
with no other element present except that of Zn and O.  
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3.2.4 (a) Time based bactericidal activity: nZnO + S. aureus and E. coli (PBS) 
Nano-ZnO particles were used under two different nutritional environments (PBS or 
ABS) and their bactericidal activity was quantified over time. When PBS suspended 
nZnO was exposed to S. aureus, there was a steady reduction in its survival (Figure 
17 & 18). Testing under different environmental factors allows for analysis of 
bacterial growth under multiple nutritional conditions, providing insight on how they 
thrive depending on environmental conditions.  Figure 17 describes the antimicrobial 
activity of the suspended nanoparticles as a percentage of the control, while figure 18 
depicts the change in population of NP-bacteria as compared to the control. The 
control in all the following time-based studies consists of bacterial suspensions (in 
any medium) without the presence of NPs.  
 
 
 
 
 
 
 
 
 
 
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 - The bacterial population (in PBS) declines for all nanoparticulate 
suspensions tested; the control remains almost constant during the 4 hour period, n=3. 
Figure 17 - The effect of nZnO particles against S. aureus suspended in phosphate 
buffered saline. The different concentrations of NPs (µg/mL) were in suspension with 
bacteria for a period of 4 hours. The population of bacteria has been calculated (each 
hour) as a percentage of control (CFU/mL), n=3, ±SEM, * = p < 0.05, ** = p < 0.01. 
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Furthermore it was observed that in general as the concentration of nZnO increases, 
bacterial survival decreases (Figure 17). The control kept relatively constant 
throughout the four hours, so allowing an accurate insight into how nZnO is able to 
reduce the population of bacteria. Nano-ZnO particulates were less active against E. 
coli, as evident from an undefined bactericidal structure of its activity (Figure 19 and 
20). While there was a general trend of decline in the E. coli population with an 
almost constant control, the lower concentrations of nZnO appeared to elicit a greater 
effect compared to the higher concentrations, indicating no dose dependent 
behaviour when compared to nZnO. Furthermore, it is important to state that 
multiple concentrations of NPs (250 µg/mL and 1000 µg/mL) lose their 
antimicrobial activity after four hours of incubation.  All studies were performed for 
over 4 hours to provide bacteria with relatively sufficient time to grow and also for 
NPs to have a time window within which observations can be made as regards to 
their nature of antimicrobial activity.   
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Figure 19 - The effect of nZnO particles against E. coli suspended in phosphate buffered 
saline. The different concentrations of NPs (µg/mL) are in suspension with bacteria for a 
period of 4 hours. The population of bacteria has been calculated (each hour) as a 
percentage of control (CFU/mL), n=3, ±SEM, * = p < 0.05. 
Figure 20 - Plot of microbial populations. Control is unaltered and with increasing 
concentrations as the population of bacteria decrease over time, with the lowest 
concentration showing the largest decline. n =3. 
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3.2.4 (b) Time based bactericidal activity: nZnO + S. aureus and E. coli (ABS) 
Nutritionally rich environments provide an opportunity to allow sufficient bacterial 
growth, this in turn allows for a better measurement of bactericidal activity of NPs in 
an environment where bacteria thrive and grow. Studies based upon these concepts 
indicate a significant increase level of bacterial growth for the provided controls 
(Figures 21 and 22). As the control culture grows the population of S. aureus remains 
relatively unchanged. However when the bacterial population is observed as a 
percentage of control at each stage of the experiment (Figure 22), it becomes evident 
that these NPs greatly reduce the bacterial population (p < 0.05). 
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Figure 21 - Antimicrobial properties of different concentrations of nZnO against S. aureus over a 
fixed period of time. Histograms represent the gradual decline of the population of ABS-
suspended bacteria. n=3, ±SEM, * = p < 0.05, ** = p < 0.01, *** = p < 0.001. 
Figure 22 - Comparison of the bacterial populations in each nanoparticulate suspension against 
time. The bacterial population control rises as the NP-suspended bacteria remain dormant or 
decrease in population, n =3. 
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Figure 23 - The antimicrobial activity of nZnO against E. coli suspended in adult bovine serum. The 
activity of different concentrations of ZnO nanoparticles in a period of 4 hours (CFU/ml (%)), n =3, 
±SEM, ** = p < 0.01. 
Figure 24 - The control has grown rapidly following 3 hour incubation. nZnO particles appear to 
have an inhibitory effect under these conditions. However increasing growth can be observed after 
4 hours of incubation, n=3. 
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While similar growth patterns were observed in this experiment as compared to the 
effect of nZnO on S. aureus, the bactericidal effects against E.coli  (Figure 23) 
indicates that there was a gradual increase in bacterial population that became 
prominent (p < 0.05) after 2 h of incubation and then significantly declined as 
bacterial growth in the control declined (Figure 24). While growth for both species of 
bacteria is less than that of control, results indicate that in both studies, there is a 
clear nZnO is more effective against S. aureus.  
3.3 Coating 
3.3.1 Optimisation of the EHDA spraying process 
 
As highlighted previously, the initial step in order to create a suitable coating was to 
observe the relevant parameters and choose a suitable a scenario where an 
appropriate setting for the desired outcome is achieved. By varying different 
parameters such as the voltage applied to the nozzle, the distance between the nozzle 
and the substrate and the flow rate of the nanoparticulate suspensions, the deposition 
area change.  Figure 25 highlight the experimental stages that lead to an 
understanding of the relationship between voltage, distance and the relative size of 
the  “circular like” deposition regions.  
 
 
 
 
 
Figure 25 – Measurements taken of 
the diameter of the almost circular 
nature of the nZnO coated surface. 
Most measurements are 
approximately equivalent and 
therefore it can be assumed that the 
coated region created by spray is 
circular-like in shape.  The two 
numbers in each row represent 
measurements taken from each side 
of the coating area (depicted in 
different colours) and the last 
measurement (6.5 cm) represent the 
diameter of fully circular coating 
region. 
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These variables (height and voltage) are also highlighted in Table 3 and their direct 
effect on the coating area diameter is shown in Figure 25 as a linear relationship. 
Furthermore findings suggest that (assuming the nozzle diameter is constant), as the 
distance of the nozzle from the sample increases, the diameter and dispersion of the 
NP suspensions also increase. Indeed further findings show that voltage applied to 
three different NP suspensions (nHA, nZnO and nTiO2) at different heights can 
slightly differ, however this difference was not found to be significant.  
 
 
For the purpose of the current study a distance of 30 mm and a voltage of 3.8 - 4.1 
kV (A uniform cone-jet spray is formed at this voltage range) was chosen as the 
standard for all coatings. This 30 mm distance allows for a full coverage of a thin NP 
based coating on multiple samples (Figure 27). Furthermore, this coating process 
also allows for multiple samples to be placed underneath the deposition area and 
therefore the relative thickness of the coating can be deduced (Figure 26).  
 
Table 3 – The distance between the substrate and the nozzle, as well as the voltage applied 
to the suspension determines the different rounded shapes produced upon the silicon wafer.  
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 Figure 27 - The above images show 1 cm2 glass samples being coated. The 
coating area is visible below the samples. This area can vary based upon different 
parameters utilised during the process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 - The linear relationship between height of the nozzle from the substrate and the 
diameter of the coated area. As the height increases, the diameter of the coated area also 
increases. This property can be used to control the coating area as well as determining the 
maximum number of samples that are ought to be coated. 
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3.3.2 Mechanical integrity  
In order to determine the thickness of the film coated on substrates, initially, titanium 
samples were coated with nZnO using different lengths of time (2, 4, 6 and 8 min).  
Upon investigation using scanning electron microscopy, samples coated for 2 min at 
a flow rate of 5 µL/min, with a concentration of 10,000 µg/mL, formed a rather thin 
layer of film on the Ti samples. This coating film did not demonstrate major physical 
fissures (cracked structures) on its surface; this is in contrast with samples that were 
coated for 4 and 6 min, respectively, where cracks were appearing. The formation of 
cracks was identified as major irregularities that appeared on the surface of the 
coating samples, identified as red marks in figure 28. The agglomerations present on 
the surface of Ti samples increased as the coating time increased and therefore the 
cracks were not so apparent on surface analysis of samples that were coated for more 
than 6 min (Figure 28).  
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Figure 28 - nano-ZnO coated Ti surface. Highlighting the physical change between different coating 
times.  The red arrows (on the left) indicate the regions where cracks have formed and arrows with 
outlined red lines indicate regions with lower magnifications. Cracks are not visible when observed at 
low magnifications (Black lines represent magnified areas). 
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3.3.3 Antimicrobial activity of coated samples: immersed in bacterial suspension 
To further validate findings as regards to the length of the coating procedure and in 
order to further test the antimicrobial potential of coated samples, a study was 
devised where glass samples, (both nWO3 and nZnO) coated for different time 
periods were tested against S. aureus. The findings confirm previous results, showing 
that nWO3 is highly unlikely to be antimicrobial. In terms of the antimicrobial 
activity of nZnO, there is a significant (p < 0.05) difference between the non-coated 
and the coated samples. It has to be stressed that while this antimicrobial effect is 
valid and the coating is bactericidal, it does not represent what occurs on the surface, 
meaning that there is no possible direct contact with suspended bacteria.  
Additionally, this antimicrobial activity provides evidence for prolonged coating of 
NPs and hints that a thicker coating may slowly compromise the antimicrobial 
potential of the coated substrates, as samples coated for 8 min were less 
antimicrobial as compared to samples coated for a shorter time period (Figure 29 and 
30).  
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Figure 29 - The glass samples were coated (10,000μg/ml) with nZnO for different time periods 
and an antimicrobial test was conducted. Comparison of the “before” and “after” values 
demonstrate antimicrobial activity (Before and after 24h incubation). n =3, ±SEM, p < 0.01. 
Figure 30 - The glass substrates were coated (10,000μg/ml) with nWO3 for different time 
periods and an antimicrobial test was conducted. Comparison of the before” and “after” values 
demonstrate the lack of antimicrobial activity (Before and after 24h incubation). n =3, ±SEM 
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3.3.4 Quantification of the coating thickness 
Based upon microscopy and antimicrobial results, a coating period of 2 min was 
therefore chosen as a fixed time for most future coatings. The thickness of this 
coating can be calculated as follows: 
Equation 1                    V/A = t 
Where t is thickness and V equates to the volume of the NP suspension that flows 
through the nozzle and A is the relative area that is covered by this suspension. 
If each sample is coated for a period of 2 min and the flow rate is 5 µl/min, then the 
final volume of the total deposited NP suspensions will equate to 10 µl/min. 
 
Also assuming that the diameter of the deposition area is 7 cm then the given area for 
a coated region can be depicted as: 
 Equation 2                         𝐴 = 𝜋3.52       
And since 10µL = 0.01cm3, then: 
 
0.01 𝑐𝑚3
28.26 𝑐𝑚2   = ⁄ 3.54 × 10
−4 𝑐𝑚 
 
This value, represents a thickness of 3.54 µm that is extremly thin. Micrographs in 
Figures 31 and 32 are a representations of how the surface of the substrate changes 
when a thin coating is applied to its surface.  
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Figure 31 - The coated nZnO substrate is visualised using scanning electron microscopy. A) A coated 
surface. Debris present is the result of preparation or environmental factors (dust particles and etc). B) The 
uniform distribution (EDX) of nZnO throughout the surface of the substrate. This demonstrates the ability 
of EHDA to uniformly coat a future implant. Coating time = 2 min. 
Figure 32 - Comparison of nano-coated and uncoated glass substrates. A) An electron 
micrograph of a nZnO coated surface, B) Micrograph of the uncoated sample, C) nZnO coated 
samples visualised using light microscopy, D) Uncoated sample.  In both cases there is a clear 
difference between the coated and the uncoated samples. 
1 mm 1 mm 
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3.3.5 Antimicrobial activity of coated samples: contact killing 
NPs at concentration of 10,000 µg/mL and various combinations (25% nZnO + 75% 
nHA, 50% nZnO + 50% nHA, 75% nZnO + 25% nHA and 100% nZnO) of nHA and 
nZnO were coated onto the surface of glass substrates and their antimicrobial activity 
against S. aureus was assessed. These studies were performed under two different 
sets of experimental conditions; bacteria suspended in PBS or ABS were placed onto 
the surface of each substrate in a humidified chamber. The results for the bactericidal 
effects of the coatings on ABS or PBS suspended bacteria are shown in Figure 33. 
The bactericidal effect of coated nZnO and nHA mixtures elicited a reduction in 
populations of bacteria as the concentration of nZnO increased. Furthermore there 
was a significant (p < 0.05) dose-dependent reduction when the control sample was 
compared to both the lowest and highest concentrations of coated nZnO. A similar 
effect was observed when PBS-suspended bacteria were placed onto the surface of 
the coated material. However the antimicrobial activity was more significant (p < 
0.001) between the control and the 100% coated nZnO samples (Figure 33).  
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Figure 33 - Bactericidal effects of nZnO coated substrates A) Antimicrobial effect of 
coated nZnO + nHA composites on S. aureus in adult bovine serum (ABS). The coated 
glass samples are coated with different concentrations of nHA and nZnO. B) Antimicrobial 
effect of coated nZnO + nHA composites on S. aureus in PBS. Coated mixtures have 
bactericidal effects as the concentration of nZnO increases. Lines compare the 
antimicrobial effect of the control with the 100% and 25% nZnO coated samples, ** = p < 
0.001, * = p < 0.05, n =4, mean ± SEM.  
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3.3.6 Antimicrobial activity of coated samples: micrograph analysis 
Further investigations as regards to the characterisation of bacteria on the surface of 
the coated material were conducted using scanning electron microscopy (SEM). 
Obtained micrographs revealed a substantial presence of adherent bacteria on the 
surface of the uncoated sample (Figure 34A), in contrast to the sparse population of 
bacteria on the surface of the coated sample (Figure 34B). The increased amount of 
debris on the coated sample can be explained as remnants of bacteria killed by the 
nanoparticulates. The coating itself (Figure 34C) also indicates the uniformity of this 
antimicrobial coating. Furthermore, while many bacterial cells on the uncoated 
surface displayed signs of cell division, individual cells on the nZnO coated surface 
were clearly physically damaged when observed at higher magnification (Figure 35). 
The healthy bacteria are depicted as going through the normal cell division process 
on an uncoated surface whereas the bacteria that are positioned upon the coated 
samples show a cluster of NPs attached onto their surface of the single bacterium. 
Limited evidence for direct contact killing of bacteria via NPs are currently 
presented.  These micrographs provide some evidence for the direct contact between 
the NPs which could eventually lead to cell rupture and cell death.  
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Figure 34 - A qualitative assessment on the antimicrobial effect of nZnO coated onto glass 
samples. A) Bacteria present on a surface without the coating B) The black arrow indicates a 
single bacterium present on the coated surface C) High resolution image of coating showing 
uniform characteristics. 
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Figure 35 - Bactericidal effect of nZnO coated surface against S. aureus. Arrows indicate two potentially dying 
bacterium. While there is no direct molecular evidence, it can be stated that the membrane has been 
compromised as compared to the control bacterium. As the NPs physically rapture the membrane of bacteria, 
the interacellular components of the microorganism could be expelled into the extracellular environment. 
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3.3.7 Patterned nZnO surfaces 
 
To explore novel ways for implant coatings and to further minimise the chance of 
coatings becoming detached from the surface of substrates, various patterned 
structures were devised and tested (Figure 36 and 37). These novel patterns were 
individually analysed and tested for their antimicrobial activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36 - Region specific coatings. The concept for a surface that has four 
different types of coating patterns on specific regions on a single sample. A sticky 
tape was used and four squared shaped structures were carved out of it. These 
structures were initially used for attaching grids that possessed different patterns. 
Each multi-grid attachment was placed under the nozzle and spraying was 
performed. The spray would travel through each grid and the coating will produce 
the relevant patterns on the substrate.  
 
91 
 
There were fundamentally four unique patterns utilised in this study. These patterns 
are depicted using images obtained by using optical microscopy (Figure 37). Two 
primary patterns identified as 1 and 2 in figure 37B, contain pillar-like structures 
with pattern 1 comprised of micro-structures that are larger pillars with each side 
measuring approximately 300 µm in length. Pattern 2 contains smaller sized 
structures that occupy more space in their provided environment.  Patterns 3 and 4 
(Figure 37B) are comprised of mainly rows. The nature of these rows differ, i.e.; 
pattern 3 has similar sized rows while pattern 4 contains elongated structures that can 
be up to 2.5 mm each, a length of an individual collection of patterns. A 3D 
representation (ScopeTek, minisee, China) of the surface of each coating is presented 
(Figure 37A) in order to graphically further clarify the structural integrity of each 
pattern structure.  Application and utilisation of these custom made grids vary 
depending on how they are fixed onto substrates and therefore the initial concept for 
a rectangular shaped paper-based plate (Figure 36), which allows grid embedment to 
be visualised was devised and subsequently the final version that was used in final 
experiments (Figure 38). 
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Figure 37 - The structure and shapes of the patterned coated surfaces.  A) The 3D 
representation of the patterned structures (ScopeTek, minisee/ImageJ). B) Patterned structures 
using light microscopy. 1 and 2) pillar-shaped patterns with large and small sizes 3) 
Rectangular-shaped patterns 4) Line-shaped rectangular patterns with various thickness and 
size. Diameter across each pattern = 2.5 mm.  
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Figure 38 - A novel method of coating patterned structures onto substrates. This 
sample has been designed so that while spraying, the resulting nanoparticulate-
suspension deposition corresponds to each individual grid presented. The size of 
each grid is approximately 25 mm and therefore multiple coatings with different 
shapes can be utilised on a single sample. If a single or multiple grids are to be 
used, others are easily covered. These qualities can be useful for both biological 
and imaging purposes. 
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3.3.7a The antimicrobial properties of patterned structures 
 
Antimicrobial assays indicated that, compared to control, regions with small square 
shaped pillars are essentially more effective in killing bacteria (Figure 39). Large 
clusters and agglomerations of nZnO are not as effective and while not significant as 
compared to the control (p < 0.05), they cannot be branded as “effective” as nano-
coatings and therefore providing a valuable insight into how future nano-based 
coatings could be designed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39 -The antimicrobial activity of the patterned samples compared to control.  Patterns 1 
and 2 elicit significant antimicrobial activity when compared to control and patterns 3 and 4. 
(All pattern numbers refer to patterns identified in figure 37), * = p < 0.05, n = 3, ±SEM. 
* * 
Pillar-shaped 
Row-shaped 
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The current results support the hypothesis that metal oxide NPs can be utilised as 
antimicrobial agents. An evaluation of the initial results (obtained from the MIC and 
MBC studies) supports this concept. In both the MIC and MBC studies, it was 
observed that NPs such as copper (II) oxide (CuO) and the novel silver mixtures 
(70% wt Ag + 30% ZnO and CuO) are highly antimicrobial. The results also indicate 
that a nanoparticulate such as WO3 is possibly antimicrobial with more inhibitory 
properties than bactericidal. The values obtained as regards the MIC suggest that 
WO3 is able to inhibit the growth of bacteria, almost as efficiently as the other 
nanoparticulates tested. This in itself is a novel finding because until recently 
tungsten oxide nanoparticulates had not been tested for their antimicrobial properties 
and were only utilised for industrial purposes (Lu et al., 2012). Furthermore, the MIC 
and MBC values for CuO are among the lowest in the present study. These findings 
are not surprising since the antimicrobial potential of CuO has been previously 
documented (Vargas-Reus et al., 2012). As a result of its toxicity towards eukaryotic 
cells, CuO is unlikely to be utilised for any medical related purposes in the near 
future (Fahmy and Cormier, 2009). Based on both the MIC and MBCs, both silver 
mixtures instigated strong bactericidal effects. Furthermore, time-based bactericidal 
studies confirmed that these mixtures were able to cause a significant reduction in 
bacterial population in a relatively short period of time. It is a well-known fact that 
silver NPs alone can show strong bactericidal effects against both gram positive and 
negative species (Morones et al., 2005, Sondi and Salopek-Sondi, 2004, Shahverdi et 
al., 2007). However, over-use of silver in various compounds, such as in cosmetics 
and solely as an antimicrobial agent will almost certainly contribute to the 
acquisition of new types of bacterial resistance (Chopra, 2007). Finally, the obtained 
results for both the MIC and MBC determinations for nZnO show that these NPs are 
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not able to display any visible antimicrobial activity within the provided time frame. 
This is possibly due to the nature of the experiment that will be addressed in the 
limitations section. Subsequently results for these experiments indicated that nZnO is 
antimicrobial (against both E. coli and S. aureus) and in contrast to our previous 
finding, nWO3 lacks this ability. A similar pattern of killing was further confirmed 
when nWO3 and nZnO coated samples were submerged and exposed to suspensions 
of bacteria. This confirmed that tungsten oxide is not a suitable novel antimicrobial 
for the purposes of the current study. A coated sample floating in medium with 
suspended bacteria is not a direct way of determining the antimicrobial activity of a 
coating and it is possible that the antimicrobial activity is partly due to elution of ions 
as compared to direct physical contact. Therefore further experiments were 
conducted with nZnO as the key NP under consideration.  
In the human body and indeed within the structure of the bone there is no specific 
homogeneity, being comprised of nerves, blood vessels as well as areas within the 
trabecular bone that appear almost “lifeless”. Therefore it is hard to mimic an 
environment whereby all these conditions are equally met. Tested nZnO under two 
different environments (ABS and PBS), indicates a phenomenon that has previously 
been observed in some recent studies (Premanathan et al., 2011). The results indicate 
that pure nZnO particulates seem to be selective towards S. aureus and while 
exerting an antimicrobial effect on E. coli, its effect is unquestionably less significant 
and scattered, with some low concentrations of NPs showing enhanced antimicrobial 
activity at higher concentrations. This finding is therefore relevant for applications 
related to medical coatings. Since most bone implants, predominantly orthopaedic, 
suffer from infections often caused by gram positive pathogens, this result is 
encouraging. Indeed it is suggested that nZnO is also highly antimicrobial to some 
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pathogens that are involved in dental-related infections, i.e. both facultative and 
anaerobic species (Vargas-Reus et al., 2012).  
Using S. aureus suspended within different environments (as described above), the 
antimicrobial activity of coated surfaces was tested. The antimicrobial test method 
used in this study was novel since it allowed the investigator to closely monitor the 
interaction between the surface of a coated sample and the suspended bacteria. The 
low amount (in volume) of bacterial suspension that is placed onto the surface of the 
coated substrates allows for a closer interaction between the nanoparticulate coated 
surface and bacteria. Indeed if one considers the shape of these NPs (rod shaped 
structures, with sharp edges), their importance as agents capable of “stabbing” 
bacteria becomes apparent. It has been demonstrated that in nature, the process of 
natural selection has evolved mechanisms in order to develop such defence against 
pathogens. One remarkable example of this naturally occurring nano-surface defence 
is the cicada wing. The nanopillars present on the cicada wing surface have the 
capability to penetrate and kill bacteria (Hasan et al., 2013). Of course there is no 
direct correlation between the present study and a naturally occurring antimicrobial, 
however qualitative results obtained (with both S. aureus and E. coli) suggest 
membrane disruption and cellular disintegration, possibly due to physical interaction 
between the NPs and bacteria. These findings indicate that in both environments the 
nano-surfaces with an ascending concentration of nZnO can be bactericidal. Many of 
the current antimicrobial coatings for bone implants depend upon release of 
bactericidal concentration of various ions (Lee et al., 2005) or elution of antibiotics 
from within their structure (Popat et al., 2007). An increase in utilisation of 
nanotubes as an alternative method is a prime example of coatings where bactericidal 
agents are loaded within or deposited upon these nanostructures (Das et al., 2009).  
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The present system provides a coating that encompasses these preferred qualities. 
Having developed a reliable coating system, a new innovative method for creating 
novel patterns was investigated and tested for their antimicrobial properties.  
Initial question was to investigate whether each unique coating pattern has a distinct  
antimicrobial “profile”. Upon examining this hypothesis the results suggest that this 
is indeed in the case. Studies have shown that micro-patterned structures as coatings 
can have significant antimicrobial activity against multiple species (May et al., 
2014), others assert that the presence of these structures on the surface of the medical 
devices prevents bacterial adhesion without the presence of any chemical 
intermediate (Reddy et al., 2011). It is therefore important to point out that these 
different shaped nano-based patterns on a substrate manifest into unique 
antimicrobial profiles that can be advantageous for future coatings and should be 
investigated further. 
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Importance of the work 
 
 
Limitations and disadvantages  
 
 
 
 
 
 
 
Relevant significance of the current research 
1 The application of multiple experimental methods in order to 
test various NPs for their potential antimicrobial activity 
2 Providing novel evidence for the antimicrobial activity of a 
composite that is comprised of two independent NPs. 
3 Observing the physical interaction of NPs against both E. coli 
and S. aureus, providing provisional evidence for this 
phenomenon. 
           4 Confirming previous findings that nZnO is selective towards 
gram-positive species (Premanathan et al., 2011), especially 
S. aureus. 
 
1 Methods used for the inhibitory and bactericidal studies need 
to be modified and carried out in more controlled 
environments. 
2 A suitable in vivo system would have been much superior for 
judging the “true” antimicrobial potential of the coated 
systems. 
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Chapter 3 
 
  nZnO as a biocompatible implant coating material 
 
1. Introduction 
Apart from their antimicrobial activity, the biocompatibility of NPs, particularly that 
of nZnO, is of outmost importance because of their potential toxic effect towards 
eukaryotic cells (Bai et al., 2010). It is understood that, when in suspension, most 
NPs can cause eukaryotic cell death or apoptotic.  This chapter focuses on the 
synergic activity of two nanoparticulates, namely nHA and nZnO with eukaryotic 
cells. The following is a review of their physiochemical effects as directed to bone 
and its microenvironment.  
1.1 Nano-HA 
Chemical modifications to the surface of bone implants affect cell behaviour, shape 
and metabolic activity. Therefore, based on observations,  a vast expanse of materials 
as well as methodologies have been devised in order to improve bone integration 
(Wennerberg and Albrektsson, 2009). One of the first materials used for surface 
enhancements was hydroxyapatite (HA). This biomaterial is chemically related to the 
bone matrix and therefore its properties are ideal for an implant coating (see general 
introduction). While nHA has been used for a number of years, active research is 
being carried out to further study its effects on osteoblasts and bone formation. It has 
been established that nanostructures are of particular interest in that they can promote 
osteoconduction, bioresorption and make more intimate contacts with the structure of 
bone (Noor, 2013). This close proximity of the surface of the coating and bone 
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structure allows for apatite formation which is a direct result of ion exchange 
between the coated surface and body fluid. Recent studies indicate that HA solubility 
and therefore calcium release increases if this biomaterial is in a nano-form 
(Meirelles et al., 2008). Furthermore, bone grafts made with this nanoparticulates 
demonstrate increased bone healing through osteoblast activation (Noor, 2013).  
1.2 Nano-ZnO 
During the process of implantation, NPs can be scraped off the implant surface and 
be distributed within the body, which can lead to potential toxicity. Studies have 
shown that ingested nZnO particles display slow absorption rates and a decreased 
systemic absorption when compared to zinc ions alone in vivo. It has been further 
suggested that most NPs, regardless of size or surface charge, are excreted through 
faeces, indicating that while not entirely safe, the majority of NPs are excreted (Lee 
et al., 2012a).  Another study indicated that upon oral injection tagged nZnO 
particles were able to penetrate several organs but no traces of these tagged NPs were 
found in the bone. These NPs were compared to two different fluorescent agents that 
were both detected upon ingestion (Lee et al., 2012b).  However, orally 
administrating NPs into subjects does not simulate the scenario where an implant is 
inserted into bone, the main difference would be the immobility of the NPs on coated 
materials. 
 The cytotoxic effects of nZnO have been extensively investigated and no cause of 
toxicity has been determined. A study looking at the mechanistic effects of 
suspended nZnO against macrophages concluded that apoptotic events did not occur 
because of the physiochemical properties of nZnO or the conventional major 
phagocytic oxidant generating pathway (Wilhelmi et al., 2013). Furthermore the 
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study indicates that these apoptotic events are concentration based. As the 
concentration of the nanoparticulates increases, ROS-mediated pathways are 
triggered that result in DNA damage and therefore cell necrosis. The authors finally 
concluded that these mechanisms are not entirely known and thorough investigations 
are required (Wilhelmi et al., 2013). A recent separate study monitoring the toxic 
effects of nZnO particulates concluded that sub-acute exposure of these 
nanoparticulates in mice results in minimal inflammatory responses, challenging the 
contradictory nature of  ZnO nanoparticulate research (Adamcakova-Dodd et al., 
2014).  
 
1.3 Coated nHA 
While the use of nHA has been extensively investigated in both fields of dentistry 
and orthopaedics, less is known about its nano-state. A study measuring the 
osteoblast activity on porous titanium surface indicates an improvement of 
proliferation and differentiation when exposed to nHA coated surfaces as opposed to 
a plain porous Ti-based implant (Shi et al., 2013). Nano-HA facilitates 
biocompatibility and osteoconductivity among other factors. However, because of its 
slow biodegradable nature, it is often demonstrated that its application in conjunction 
with other organic or synthetic materials such as PLGA or collagen will enhance its 
drawbacks (Christenson et al., 2007). A quality that seems to be universal to most 
biocompatible NPs, and especially, nHA, is its crystal structure. Researchers claim 
that nanophase HA has a crystal structure that bears a close resemblance to that of 
bone. This observation is enhanced by evidence provided in multiple studies that 
have shown in vivo evidence for increased bone formation when metal-based 
implants were coated with nanophase HA (Li, 2003, Zakaria et al., 2013). Therefore 
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it can be inferred that nHA provides changes in cellular interactions that ultimately 
lead to an increased tissue response.  
1.4 Coated nZnO 
Limited studies have been conducted as regards to the function of nZnO particulates 
for medical implant coatings. Most of these studies have been conducted very 
recently, making this field relatively unexplored (Zaveri et al., 2010, Seil and 
Webster, 2008, Brunner et al., 2006). A recent study demonstrated found that a novel 
polyvinyl chloride (PVC) nanocomposite incorporating fine ultra-sonicated nZnO 
particulates can enhance fibroblast density after 18 hours of incubation (Paul et al., 
2014).  In contrast, a recent study indicates that increasing concentrations of nZnO 
nanoparticulates in polymer matrices causes a decline in cell viability. Other means 
of incorporating ZnO into coatings have also been used recently. The following 
investigations are an attempt to understand the biocompatibility properties of nZnO 
particulates relevant to bone cells.  
2. Materials and Methods 
 
2.1 Nanoparticles utilised for coating 
Metal oxide NPs were synthesised using the flame pyrolysis method as used by 
Johnson Matthey plc (JMTC). The average surface area was determined by Brunauer 
Emmett Teller (BET) analysis at JMTC. Nano-HA particles were made by the 
process of wet precipitation between calcium hydroxide (Ca(OH)2) and 
orthophosphoric acid (H3PO4). Handling and storage of these NPs was performed in 
a manner to avoid biological and environmental harm. NP suspensions were 
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collected, dried and incinerated.  The NPs tested were: Zinc Oxide (nZnO),Titanium 
dioxide (nTiO2), Cupric Oxide nCuO and nHA. Both nZnO and nTiO2 were 
subsequently analysed by transmission electron microscopy (See Chapter 2, section 
3.1).  
2.2 Nanoparticulate suspension-derived supernatants 
 
Nano-ZnO, nTiO2 and nCuO particulate suspensions (10,000 µg/mL) were placed in 
2% FCS DMEM and left in a shaking incubator for 10 days at 37°C. After 10 days 
samples were removed and transferred into a 50 mL centrifuge tube and spun at 1000 
RPM (160 g) for 5 min. The supernatant from each sample was removed and filtered 
using a 0.22 µm filter (EMD Millipore, UK). Osteoblast-like cells (UMR-106 and 
MG-63) were seeded at a density of 1× 105 per well in a 24 well plate. A volume of 1 
mL of DMEM (with 2% FCS, 1% P/S) was added to each well and incubated at 
37ºC, 5% CO2 for 24 h to allow a cell monolayer to develop. The medium in each 
well was replaced with filtered supernatant or plain media (control) and incubated for 
0, 2 and 4 h respectively.  
 
2.3 Nanoparticulate suspension and composites 
Nanoparticulate suspensions: Different concentrations (2500, 5000 and 10,000 
µg/mL) of nZnO suspension were made in 100% ethanol and sonicated thoroughly 
prior to electrohydrodynamic atomisation (EHDA) spraying. 
Nanoparticulate composites:  For preparation of the composite mixtures, two 
different suspensions of nZnO and nHA were made with equal concentrations of 
10,000 µg/mL (100% nHA, 25% nZnO + 75% nHA, 50% nZnO + 50% nHA, 75% 
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nZnO + 25% nHA and 100% nZnO). From these suspensions a known volume was 
added to produce the required concentration of NPs within each composite.  
2.4 Biocompatibility and cell proliferation studies   
2.4.1 Cell culture 
UMR-106 (Rat osteosarcoma), MG-63 (human osteosarcoma) and human 
mesenchymal stem cells (hMSC) were used in this study. The majority of 
investigations were carried out using UMR-106 cells. Human MSCs were utilised for 
qualitative adhesion observations. MG-63 cell-lines were utilised for both qualitative 
& quantitative adhesion observations as well as ELISA studies.  
Frozen cells were quickly thawed and cultured in high-glucose DMEM with 2% 
FCS, 1% penicillin and 1% L-glutamine. The cells were incubated for 48 h at 37ºC, 
5% CO2 and then detached using Trypsin/EDTA. Trypsinised cells were resuspended 
with 5 mL of medium, placed in 10 mL tubes and centrifuged at 800 g for 5 min. 
Supernatant was removed from each tube and fresh media was then added to the cell 
pellets. Osteoblasts were dispersed, suspended, counted and seeded onto coated 
samples with a density of 1× 104 cells. Samples were incubated at 37ºC, 5% CO2 for 
2 h to allow cell-substrate adhesion. 
2.4.2 Proliferation assay 
The proliferation of the UMR-106 cells was assessed using Alamar Blue 
(alamarBlue® -AbD Serotec). The reagent was diluted with normal growth medium 
(1:10 dilution) and stored at 4ºC prior to use. A population of 1×104 osteoblasts were 
seeded onto coated glass samples in a 24 well plate (n = 4 per condition).  Seeded 
cells were left for a period of 15-20 min in the incubator to ensure adhesion and 1 
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mL of medium was added to each well for overnight incubation.  At 1, 5 and 10 days 
10% of the volume of the medium in each well was replaced with reagent medium. 
The plate was then incubated for a period of 4 h and 100 µL of the supernatant was 
removed from relevant wells and added to a 96 well (Black Falcon) plate. 
Fluorescence was measured using a fluorescent plate reader (FLUstar OPTIMA, 
BMG Labtech, Germany) at wavelengths of 570 nm (excitation) and 600 nm 
(emission).   
2.4.3 Cytotoxicity Assay  
LDH release from UMR-106 cell lines was measured using a commercially available 
kit (LDH-Cytotoxicity Assay Kit II (500 assays) (ab65393)) and carried out 
according to the manufacturer’s instructions. 
 
1) LDH release: osteoblasts exposed to NP suspension supernatants 
To examine the possible effects of released ions on osteoblast viability, nZnO 
particulates were suspended in 2% FCS DMEM (10,000 µg/mL) and left in a shaking 
incubator for 1, 5 and 10 days at 37°C. Nano-TiO2 particulates were also tested in a 
similar manner. At each time point, samples were removed and transferred into a 50 
mL centrifuge tube and spun at a speed of 160 g for 5 min. The supernatant from 
each sample was removed and filtered (0.22 µm , EMD Millipore) Osteoblasts were 
seeded at a density of 1× 104 per well in a 96 well plate. A volume of 100 µL of 
DMEM (with 2% FCS) was added to each well and incubated at 37ºC, 5% CO2 for 
24 h to allow a cell monolayer to develop. The medium in each well was replaced 
with 100 µL of the filtered supernatant or Lysis Buffer (positive control) and 
incubated for 40 min. The plate was centrifuged at 600 g for 10 min and 10 µL of the 
supernatant was transferred to a new 96 well plate. A volume of 100 µL of the LDH 
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reaction mix was added to each well and incubated for a further 30 min. Absorbance 
for all samples and controls was measured at a wavelength of 450 nm using a plate 
reader (FLUstar OPTIMA, BMG Labtech, Germany).  
 
2) LDH release: osteoblasts exposed to supernatants derived from nano-coated 
samples 
The coated samples were placed in a 24 well plate containing 2 mL of 2% FCS 
DMEM in each well. The samples were then left in a shaking incubator (37ºC, 200 
rpm) for periods of 1, 5 and 10 days.  In parallel, 1×104 cells per well were seeded 
into a separate 24 well plate and incubated at 5% CO2. A volume of 1 mL of DMEM 
from each time point was subsequently added to cells. Osteoblasts were then 
incubated for a further 24 h and 100 µL of each well was removed and dispensed into 
a 96 well plate and LDH release was measured. 
 
2.4.4 Alkaline phosphatase activity 
The differentiation of the UMR-106 cells on the nZnO coated samples was 
determined by measuring alkaline phosphatase release. A population of 1×104 cells 
were seeded onto coated glass samples in a 24 well plate and left at 37°C in an 
incubator with 5% CO2 for 1, 5 and 10 days respectively. For the ALP assay, one 
tablet of 4-nitrophenyl phosphate disodium (SIGMA-aldrich, Dorset, UK) was mixed 
with 8 mL 0.1 M Trizma Hydrochloride (pH = 9.5) and 15 µL of 2 M MgCl2. Before 
addition of the reaction solution to the cells, each well was washed with PBS three 
times. A volume of 1 mL of the reaction solution was added to each well containing 
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the cell seeded coated samples. The 24 well plate was left at room temperature for 
approximately 10 min for the reaction to take place. Addition of 0.5 M NaOH was 
then used to stop the reaction. Subsequently, 100 µL aliquots were removed from 
each well and transferred into a 96 well plate and the absorbance read at 405 nm 
using a plate reader (FLUstar OPTIMA, BMG Labtech, Germany).  
2.4.5 Cytokine release measurements 
ELISA was performed in order to quantify cytokine release.  MG-63 human 
osteosarcoma cells were seeded onto glass samples (as described previously) and 
cytokine release (TNF-α and IL-6) were subsequently measured according to the 
manufacturer’s protocol (Thermo Scientific, UK).  
2.5 Microscopy 
2.5.1 NP characterisation 
1) Transmission electron microscopy: ZnO along with TiO2 NPs were placed in 5 
mL of distilled water and sonicated to provide a homogenous suspension. Carbon 
film grids (400 Mesh Cu, Agar scientific) were briefly dipped into the 
nanoparticulate suspension and left at room temperature to air dry. The grids were 
transferred into the TEM (Philips CM 12) and subsequently analysed. 
 
2.5.2 Cell morphology 
1) Optical microscopy: Standard inverted light microscopy (Nikon Eclipse TE2000-
5) was used to observe cellular growth at every stage. A population of 1×105 of cells 
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were seeded onto coated samples and their morphology and distribution was 
monitored over time. 
2) Scanning electron microscopy (SEM):  Both coated and uncoated substrates that 
were seeded with cells were placed into 3% Glutaraldehyde (SIGMA Aldrich, 
Dorset, UK) in 0.1 M Cocadylate buffer (SIGMA Aldrich) for a period of 24 h. Each 
sample was then dehydrated using ascending concentrations of ethanol: 20%, 50%, 
70% and 90% for 10 min each and 100% ethanol for 30 min. Finally the samples 
were dried using hexamethyldisilazane (HMDS) (SIGMA Aldrich) for 5 min. 
Samples that lacked the presence of cells were cleaned with 100% ethanol and 
processed without the dehydration process. Furthermore, glass samples were 
mounted onto stubs and made conductive by the application of conducting carbon 
cement (Agar Scientific, UK) between the sample and the stub. All samples were 
gold coated and directly transferred into the scanning electron microscope (FEI 
Quanta 3D FEG) with an average working distance of 12 mm and an accelerating 
voltage of 5kV.    
2.5.3 Immunofluorescence 
Cells were fixed with 4% paraformaldehyde (PFA), incubated for 10 min in 
permeabilisation buffer (PBS with 0.2% Triton X-100) and subsequently blocked 
with 2% bovine serum albumin (BSA). Samples were incubated with primary 
antibody (4 mg/mL mouse anti-paxillin; Santa Cruz, Inc., U.S.A.) for 24 h at 4°C. 
Subsequently NP coated coverslips were  washed with PBS and incubated for 45 min 
at room temperature in the dark with Alexa Fluor® 568 conjugated rabbit anti-mouse 
secondary antibody (Invitrogen Molecular Probes, U.K.).  Alexa Fluor® 488-
phalloidin staining was applied to visualise F-actin (Invitrogen Molecular Probes, 
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U.K.). Imaging was performed with a Leica DM4000 epi-fluorescence microscope 
(Leica, Solms, Germany). 
2.5.4 Sirius red assay (collagen assay)  
The Sirius red assay is often used to stain for collagen deposition. This solution was 
obtained from the Bart’s and The London School of Medicine, (The Royal London 
Hospital). Samples were coated with 100% nZnO, 100% nHA and 50% nZnO + 50% 
nHA. An identical population of osteoblasts (1×105) was seeded upon coated and 
uncoated samples. All samples were incubated overnight at 37ºC, 10% CO2. The 
medium in each well was removed and all samples were gently washed with PBS 
and transferred into a new 12 well plate. Subsequently, 100 µL of the Sirius red 
solution was added to each sample in order to fully cover the surface. All samples 
were left submerged in the solution for 1 h and immediately washed with 70% 
ethanol. Samples were left at room temperature for a further 15 min to dry and then 
mounted onto glass slides for microscopy. Normal images were obtained using a 
650D DLSR. Magnified micrographs were obtained by utilising a DEM130 (1.3 M 
pixels, MiniSee). Image thresholding was conducted using ImageJ, This refers to a 
software-based technique whereby an image background is changed in order to 
highlight the regions of interest.  
2.6 Statistical analysis 
One way ANOVA (GraphPad Prism 5) was used for focal adhesion studies and 
student’s t-Test were used to analyse the difference between quantitative 
measurements. When, p < 0.05, the results was considered statistically significant. 
 
111 
 
3. Results 
3.1 The effect of NP supernatants on osteoblasts 
 
Osteoblasts were exposed to supernatants derived from three different 
nanoparticulates: nZnO, nTiO2 and nCuO, each at 10,000 µg/mL. Figure 40 
demonstrates the morphological change for the seeded osteoblasts. At hour 0 there 
were no visible morphological changes present, where hour 0 represents the 
morphological state of the cells after 5 min of exposure to supernatants.  The 
morphological changes become evident after 2 h of incubation. At this stage, stark 
differences can be observed between the control and osteoblasts, particularly with 
UMR-106 cells exposed to nCuO NP supernatants. The morphology for both MG-63 
and UMR-106 cells was compromised, resulting in cellular detachment. 
Furthermore, the effect of nZnO supernatants on UMR-106 becomes more evident as 
the incubation time increases. While still attached to the surface of the culture flask, 
their morphology dramatically changed. Cells no longer exhibited their characteristic 
“flattened” shape and as a result many gaps emerged between individual and their 
neighbouring cells.  This extreme response was not observed for MG-63, however 
compared to the control and hour 0, cells possessed elongated, thinner and well 
defined protrusions, indicating the possible inception of cellular detachment. At 4 h, 
nCuO supernatants visibly destroyed both cell types. Furthermore, no structural or 
morphological change was observed in both cell types upon exposure to supernatants 
of nTiO2 NPs. 
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Figure 40 - Supernatants of nZnO, nTiO2 and nCuO on osteoblast-like cells (UMR-106 and MG-63) after 0, 2 and 
4 h of incubation. The morphological differences at each time point are taken into consideration as to assess the 
toxicity of each supernatant. 
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 3.2 Effect of nZnO on morphology of osteoblast-like cells 
Osteoblasts (UMR-106) were cultured on different concentrations of nZnO coatings 
(2500 µg/mL, 5000 µg/mL and 10,000 µg/mL). Bright field microscopy revealed 
greater number of cells at 2, 24 and 48 h and minimal cell death (Figure 41). Cell 
interaction with nZnO at different exposure times to coated samples was further 
characterised by SEM. UMR-106 and MG-63 cells revealed a spindle shaped 
morphology, characteristic of a normal osteoblast (Figures 42 - 46). Cell morphology 
was also largely normal in hMSCs, with no signs of physical cellular stress (Figures 
47 - 49). Cellular stress based upon electron micrographs are often depicted as 
numerous large blebs (sphere like protrusions) occurring on the surface of the 
individual cell, indicating the process of apoptosis. Osteoblasts also displayed 
filopodia projections that are in close contact with the nZnO surface or in proximity 
to neighbouring cells. Adhesion to coated nZnO in culture was further investigated 
by immunofluorescent imaging of the focal adhesion protein paxillin.  Cells adhered 
to higher concentrations of nZnO or the mixture of this NP with nHA showed 
spreading features, with increased punctate paxillin staining and stress fibres (Figure 
50 and 51). Thus nZnO coatings allow osteoblast attachment and focal adhesion 
formation.  
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Figure 41 - Seeded UMR-106 (osteoblast-like cells) on the surface of nZnO coated 
glass samples. The samples were coated with increasing concentrations of nZnO to 
observe any morphological changes. Phase images show increased numbers of cells at 
2, 24 and 48 hours. Red arrows indicate initial attachment of osteoblasts to the 
substrates after 2 hours of incubation and Black arrows show the similarity of 
osteoblast confluency between a coated and non-coated substrate.   
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Figure 42 - Osteoblast-like cells (UMR-106) attached to the nZnO coated substrates.  An osteoblast like cell 
is extending its filopodia (red arrows) projection to adhere to the coated surface. 
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Figure 43 - Osteoblasts exhibiting projection-like structures in order to secure and settle onto the nZnO-coated 
surface. 
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Figure 44 - MG-63 osteoblasts on a nZnO coated surface. Micrograph shows two communicating cells on a 
surface coated with nZnO particulates. 
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Figure 45 - MG-63 cells on nZnO coated surfaces.  Human osteoblast-like cells on a coated surface, surrounded 
by other already adhered osteoblasts. 
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Figure 46 - Two MG-63 (osteoblast like cells) interacting on the 100% nZnO coated surface (10,000 µg/mL). 
The uniformly nZnO-coated surface is visible below and beneath the cells. The active mini cell membrane 
filopodia suggest a very healthy, metabolically active cell.  
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Figure 47 - hMSC cells are able to attach to the surface of composite coated substrtaes. An SEM and an optical 
representation of mesenchymal stem cells adhered to the surface of nano-coated substrates.  
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Figure 48 - hMSC adhered to the nZnO coated surface. C & D) Cells adhered to a suitable surface and eventually 
become flattened. Other attached cells can be observed in close proximity to all these adhering cells. 
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Figure 49 – Mesenchymal stem cells on a nZnO coated surface. A) Electron micrograph of a cell monolayer 
of hMSCs, B) Light microscopy representation of the same monolayer, C) Electron micrograph showing a  
cell elongating its filopodia for an appropriate place to adhere 
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Phalloidin, a toxin that binds to actin filaments allows clear visualisation of the 
structural integrity of fixed cells. Actin filaments are visualised as red fine structures 
that are viewed within the cytoskeleton of the cell.  The present findings suggest that 
cells attached onto all coated samples, have a stable morphological integrity.  
Adhesion points, whereupon osteoblasts make contact with the nano-coated surface, 
are highlighted by the level of paxillin expression. The red-coloured adhesion 
markers (highlighted by the white arrows) specify regions where cells have made 
contact with the surface of the coating. Qualitative assessment of the level of paxillin 
expressed in each individual staining suggests an increased expression present for 
samples that have an increased concentration of nZnO coated on their surfaces. This 
observation is verified by the quantitative analysis of the paxillin expression points 
(Figure 52). The focal adhesion counts for UMR-106 cells show no significant 
difference between all coated samples as compared to the control or within multiple 
samples. This is different for MG-63 focal adhesion counts where there is a 
significant increase in counts (p < 0.01) of nZnO + nHA composite coatings in 
comparison to other coatings. Furthermore, the nZnO alone coating has the second 
highest focal adhesion counts as compared to nHA and the uncoated surface 
(control).   
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Figure 50 - Effect of nZnO and nHA on actin cytoskeleton and focal adhesions. Fluorescent images of actin 
filaments (arrow heads in A, D, G, J) and focal adhesions (arrows in B, E, H, K). Human osteoblast-like cells 
(MG-63) cultured for 24 hours on 100% nZnO, nHA and 50%  nZnO coatings show more marked focal 
adhesions (E, H, K) compared to control (B). Scale bars = 50μm (Memarzadeh et al. 2014). 
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Figure 51 - Effect of nZnO and nHA on actin cytoskeleton and focal adhesions. Fluorescent images of actin filaments 
(arrow heads in A, D, G, J) and focal adhesions (arrows in B, E, H, K). Human osteoblast-like cells (UMR-106) 
cultured for 24 hours on 100% nZnO, nHA and 50%  nZnO coatings show more marked focal adhesions ( E, H, K) 
compared to control (B). Scale bars = 50μm (Memarzadeh et al, 2014). 
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Figure 52 - Comparison of focal adhesion points of osteoblast-like cells on coated 
samples. No significant change in focal adhesion (FA) expression (paxillin) was observed 
for UMR-106, while MG-63 cultures on composite mixture of 50% nZnO and 50% nHA 
showed an increase in FA expression.  n =5, p < 0.01, SD+.  
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3.3 Osteoblast cytotoxicity, viability and proliferation 
Lactate dehydrogenase (LDH) production and release from supernatants derived 
from suspended NPs (TiO2 and ZnO) (Figure 53 and 54) and coated nZnO (in cell 
culture medium) were measured from UMR-106 cells (Figure 55 and 56). No 
significant LDH release was observed under both conditions.  
Moreover, osteoblasts seeded on NP surface coatings demonstrated an increase in 
proliferation (Figure 57) and alkaline phosphatase release (Figure 58), with the 
higher nZnO percentages showing an increased activity in both. While the general 
trend for proliferation for days 5 and 10 is increasing as the concentration of coatings 
of nZnO is increased, this trend does not apply to cells seeded onto composites of 
nZnO + nHA (50% nZnO + 50% nHA and 25% nZnO + 75% nHA). Osteoblasts 
seeded on the composite mixtures do not show any significant proliferative activity 
between days 5 and 10. This trend was found to be similar when findings for ALP 
activity was similarly evaluated. In both cases, the relative activity of cells when 
seeded onto mixtures of nHA and nZnO show decreased activity when compared to a 
sample with no coating.  
 In addition, measurement of cytokine release (TNF-α and IL-6) revealed that no 
inflammatory response was induced when cells were allowed to adhere on coated 
surfaces (data not shown). 
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Figure 53 - Cytotoxicity assay. Lactate dehydrogenase (LDH) release from cells 
exposed to supernatants of suspended nZnO and nTiO2. Each suspension was incubated 
for an extended amount of time (1, 5 and 10 d) and its supernatant tested on UMR-106 
cells; n = 4, ±SEM 
Figure 54 - Percentage cytotoxicity instigated upon UMR-106 cells by supernatants of 
suspended nZnO and nTiO2. n =4, ±SEM. 
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Figure 56 - Percentage cytotoxicity of coated nZnO samples instigated upon osteoblasts. 
n =4, ±SEM. Significance compares the level of toxicity of the nZnO coated substrate to 
both background and low control, p < 0.05. 
Figure 55 - Cytotoxicity assay. Lactate dehydrogenase (LDH) release from the seeded 
UMR-106 cells (1 × 104). High-control = lysis buffer + osteoblasts, Low Control = cell 
culture media + osteoblasts, Background control = cell culture media. n =4, ±SEM. 
** 
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Figure 58 - Alkaline phosphatase (ALP) activity in UMR-106 cells. ALP release was 
measured from cells on coated mixtures at 1, 5 and 10 days. The asterisks indicate the ALP 
release between 100% nZnO and both 50% and the control. Mean ± SEM, n=4, * = p < 0.05 
 
Figure 57 - Proliferation assay (AlamarBlue) of UMR-106 cells. Cells were monitored on 
mixtures of coated samples at three time points, day 1, day 5 and day 10. Mean ± SEM, n=4, 
* = p < 0.05, ** = p < 0.001. 
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3.4 Collagen expression 
Collagen expression for each sample was observed using Sirius red staining. Regions 
where collagen expression was prominent are stained red with a yellow background. 
Samples coated with 50% nHA + 50% nZnO and 100% nZnO showed an increased 
level of collagen production as compared to the control and 100% nHA. Also a 
comparison between these two samples indicates an equal level of collagen 
deposition.  This was visualised when observed with an optical microscope, where a 
clear distinction between stained regions and the other non-stained regions were 
evident (Figures 59).  At day 5, dispersed collagen expression for all samples was 
observed, the homogeneity of these scattered regions being greater for the 50/50 
composite where stained regions were not so confined to a specific region and were 
comprised of smaller stained regions that together form the broader stained regions. 
At day 15, a more concentrated collagen deposition at all regions can be observed.  
This was very well defined and distinct for all samples compared to control, 
particularly on the 100% nZnO coated substrate. An additional observation to 
identify regions stained for collagen was carried out by adjusting the threshold for 
the colour red (Figure 60 and 61). This allowed for a unique insight into the 
distribution of collagen production on each specific substrate, giving an accurate 
comparison between all samples. 
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Figure 59 – Sirius red stained osteoblasts (UMR-106) 
seeded onto coated glass substrates for 5 and 15 days. Red 
regions indicate collagen expression. Controls = uncoated 
coverslips. 
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Figure 60 – Collagen staining of osteoblast cultures after 5 and 15 days. 50% nZnO + 50% nHA, 100% nZnO 
and 100 nHA coated surfaces were compared to control. Regions stained with the colour RED are considered 
to be comprised of collagen type I. Light microscopy = objective x4. 
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Figure 61 – Threshold-adjusted stained regions. These adjusted micrographs highlight regions of interest 
for each sample. All stained regions are considered as clusters of osteoblasts that have expressed 
collagen type I and the white regions are not stained. Thresholding refers to an image processing 
technique where a specific region of interest is singled out against the background to highlight the 
region of interest. In the present case the region of interest are stained with Sirius red for Collagen. Red 
arrows depict regions of stained collagen while the green arrow depicts non-stained regions 
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4. Discussion 
It is essential to provide evidence for the biocompatibility of a prospective bone 
implant. The term biocompatible refers to an object with overall properties that are 
not detrimental in vivo.  This implies that upon exposure to osteoblasts or other 
relevant cells, the nano-coated prototype remains non-toxic or refrains from causing 
an inflammatory response or cell death (Williams, 2008). A series of limited but 
thorough studies have been carried out in order to address this particular issue. 
Previous chapters in this thesis dealt with the toxicity of various NPs against given 
species of bacteria. It is also necessary to observe the “indirect effect” of some of 
these NPs on eukaryotic cells, i.e. osteoblasts.  The term “indirect” refers to the 
effect that these NPs instigate when not in direct contact with eukaryotic cells, i.e. 
the exposure of cells to NP-derived supernatants. Some studies have concluded that 
most nanoparticulates, and certainly those tested in this study (nZnO, nTiO2 and 
nCuO) instigate direct damage to multicellular organisms (Moore, 2006, Mortimer et 
al., 2010, Wang et al., 2009). There is, currently, no direct evidence as to how this 
direct damage maybe caused. The current consensus in this research area speculates 
that the toxic nature of the NPs is solely due to the amount of ion release into their 
surrounding environment, while other studies suggest that these effects are a 
combination of different factors such as ROS generation and direct contact (Sharma 
et al., 2009a). Indeed, NPs are often produced via different procedures and therefore 
their effects on cells may also differ. The important distinction between direct and 
supernatant exposure of cells is the removal of the “physical” aspect of the 
nanoparticulates. Our previous provisional investigations indicate that lower 
concentrations, as compared to NPs used for obtaining the present supernatants, are 
detrimental to eukaryotic cells. CuO supernatants are more toxic than other metal 
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oxide derived supernatants on immediate exposure to cells. An immediate 
morphological change and a separation of the cells from the flask indicated that CuO 
supernatants are toxic to both cell-lines tested. This observation is in accordance with 
work that has been reported on the effect of copper on various eukaryotes (Chen et 
al., 2011, Mortimer et al., 2011). This morphological change can also occur when 
cells are exposed to nZnO supernatants; however no change is evident when 
compared to cells exposed to nTiO2 supernatants. Considering the high concentration 
of nanoparticulates, these findings are not surprising and essentially highlight the 
intricacies involved with testing for “cytotoxic effects” of these agents. By observing 
these results and evidence for osteoconductivity of titanium dioxide it can be 
deduced that nTiO2 coated implants are an option for a biocompatible coating (Wu et 
al., 2012). However this agent is optimally bactericidal under certain conditions (i.e. 
when exposed to UV or normal light) and therefore cannot be utilised as a coating 
that needs to be enclosed in a closed biological environment (Fu et al., 2005). 
Qualitative observations of cell adhesion assays indicated much potential for nZnO. 
Since all other nanoparticulates were excluded as regards to their biocompatibility, 
nZnO was tested for its direct effect on osteoblasts.  
Results obtained from time based cell culture studies on nano-coated substrates did 
not demonstrate any adverse morphological difference between osteoblasts cultured 
onto high concentration coatings and those cultured on low concentrations.   
Recently, a study investigating the effect of ZnO on osteoblasts has shown that 
synthesised ZnO nanoflowers have the capability to promote cell adhesion, 
osseointegration, growth and proliferation (Park et al., 2010). The current nZnO 
coated prototypes show that at 10,000 µg/mL, a relatively high concentration, 
osteoblasts are able to adhere and proliferate, without displaying signs of toxicity.  
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Additional evidence provided by electron micrographs confirmed these findings by 
showing cells with elongated filopodia and projections that lead to cells adopting a 
flattened shape on the nano-coated surfaces. In addition, cellular communication and 
division is also evident, whereupon osteoblasts undergo the process of mitosis on a 
surface coated with nZnO. These results are reinforced by comparative observations 
made with assessment of paxillin expression in osteoblasts. Paxillin is part of a larger 
complex of proteins, the so called focal adhesion proteins. These proteins include 
paxillin, vinculin and alpha-v beta 3 integrin. Briefly, their main function is to 
increase cellular adhesion and therefore reduce cell migration (Turner, 2000, 
Wozniak et al., 2004, Yano et al., 2004). Integrins bind to the extracellular matrix 
such as collagen and fibronectin, allowing the cell to attach to a suitable substrate.  
Furthermore, expression of paxillin can be seen in the current studies whereupon 
osteoblasts exposed to coatings with increased concentrations of nZnO express an 
equal or more levels of paxillin. Limited studies have confirmed the role of calcium 
and zinc in promoting the expression of focal adhesion points (Nayab et al., 2005, Xu 
et al., 2013). Comparatively, the expression of paxillin is relatively higher in samples 
that contain increasing concentrations of ZnO NPs. However this only applies to 
cells derived from human origin (MG-63), whereby focal adhesion points on 
coatings with mixtures of nHA and nZnO showed significant difference as compared 
with other samples. Focal adhesion counts showed no significant difference between 
all coated samples for rodent based osteosarcoma cells (UMR-106). This stark 
difference between multiple cell types highlights the intricate processes involved in 
cell adhesion and how cellular behaviour is likely to be species dependent.  In 
general, exposure to high concentrations of nanoparticulates can be detrimental 
(Sharma et al., 2009b). When eukaryotic cells are introduced to a toxic 
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environment/material, the phospholipid bilayer may rupture and intracellular 
compartments of the cell escape to the extracellular medium. Release of the enzyme 
lactate dehydrogenase (LDH) is a useful indicator of cytotoxicity (Huang et al., 
2010). In the present study, to examine exposure of cells to supernatants of nTiO2 
and nZnO, the supernatant derived from nZnO did not elicit significant toxicity when 
compared to osteoblasts placed in normal media. Although eliciting a greater 
response than nTiO2, there was no significant increase in toxicity between days 5 and 
10. Similarly, low LDH release was detected when cells were cultured onto nZnO 
coated surfaces.  
In order for early bone formation to occur, the conditions surrounding the implant 
should provide a suitable environment for osteoblast attachment and proliferation. 
Therefore it is essential that the implanted prosthesis has the capability to be both 
osteoconductive and biocompatible. This study showed an increase of proliferative 
activity after 5 and 10 days for all coated samples; this effect was greater with both 
100% nHA and nZnO coated samples.  ALP activity was also assessed using 
osteoblastic cells (UMR-106). A time dependent increase in ALP was observed with 
all samples and was associated with samples having a higher percentage of nZnO. 
This effect could be due to the role that Zn2+ plays in regulating the metabolism of 
bone. Studies report that zinc deficiency decreases calcium deposits in the 
extracellular matrix (ECM) (Hie et al., 2011). In fact ALP contains Zn as a cofactor 
and its deficiency causes the dissociation of phosphomonoester, an enzyme 
hydrolysed by ALP that is directly related to bone mineralisation (Alcantara et al., 
2011). Furthermore, the surface charge of each coating (nHA and nZnO), could have 
an effect on the ion release of these particles, as adsorption of ions onto the surface 
of the material is a possibility once a composite is formed. It can be hypothesised 
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that the reduction in ALP and proliferation, once osteoblasts are exposed to 
composites, are likely to be the cause of this adsorption, however the main 
mechanism behind this phenomena remains unknown and should be researched 
further. Furthermore it was also observed that after 5 days of incubation the cell 
metabolic activity decreased, indicating extracellular matrix formation by 
osteoblasts, which includes an increase in collagen production. Collagen synthesis is 
often considered as a well-defined sign of osteoblast differentiation and, a deficiency 
of zinc could affect its biosynthesis (Seo et al., 2010). Observations in this study 
confirm these previous findings. At day 5 the collagen (predominantly collagen type 
I) production is less prominent for all samples when compared to day 15. This is in 
agreement with findings that show collagen synthesis occurring at the late stages of 
incubation as opposed to early incubation (Alcantara et al., 2011). A quantitative 
observation by the same group suggests that samples lacking zinc, would decrease 
the ECM biomineralisation which indicates a decline in collagen type I production. 
The production of collagen is important for several reasons. Both in vivo and in vitro 
studies have shown that collagen has evolved to serve as an important component of 
bone that allows for its involvement in bone strength, toughness and multiple 
independent roles in biochemical modifications of its structure (Viguet-Carrin et al., 
2006).  The current investigation also confirms another hypothesis which states that 
collagen production at the early stages (day 1) of mineral deposition is much slower 
and almost non-existent as compared to the later stages when the ECM is fully 
formed. Furthermore, utilising a colour thresholding approach on collagen 
production indicates that nZnO and nHA can promote collagen production at an early 
stage. In conclusion, proliferative, biocompatibility and morphological assays 
conducted in vitro suggest that osteoblasts together with human mesenchymal cells 
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can reside and potentiate bone formation when placed upon or are exposed to 
supernatants of concentrations of metal oxide NPs. Coated ZnO NPs can also 
instigate a positive response in osteoblasts, promoting the initiation of ECM 
formation that in turn will mediate osteoblast differentiation leading to collagen 
production. Indeed, further evidence is required to validate the present findings via 
mechanistic and molecular studies. 
 Importance of work 
 
 
 
 
 
 
 
Limitations 
Relevant significance of the current research 
1 Molecular evidence is required to fully establish the 
current hypothesis of biocompatibility (i.e. 
expression of genes that might have had an effect on 
osteoconductivity of cells). 
2 No in vivo or ex vivo studies have been carried out. 
3 The mechanical stability of the coatings is still under 
investigation. 
  
Relevant significance of the current research 
1 Providing evidence that EHDA-coated nZnO 
samples are non-toxic to relevant eukaryotes, such as 
osteoblasts. 
2 Establishing that nZnO coated substrates are both 
biocompatible and osteoconductive. 
3 
 
4 
Understanding the potential for novel nano-patterned 
structures. 
Providing novel evidence for the adhesion of 
osteoblasts to a nano-ZnO surface in addition to 
highlighting the superiority of nZnO in up-regulating 
focal adhesion-related genes. 
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  Chapter 4 
 
1. Future innovations 
The following chapter will discuss concepts and ideas relevant to this thesis. These 
require further validation and their absolute validity of these findings needs to be 
strengthened with further additional experiments. The following segments constitute 
of four sections in which various novel aspects as regards to further biological and 
physical capabilities of nZnO will be reviewed. These results are based upon careful 
observations of some of the author’s findings. 
1.1 The role Ion release from NPs  
Ion release is an important factor in both antimicrobial and osteoconductive 
processes (Kim et al., 2005). It is important to quantify the amount of ions released 
into the surrounding environment. While there is no clear evidence as to what 
mechanism is exclusively responsible for the toxicity of nZnO, in vivo and in vitro 
studies have shown that its effects on both eukaryotic and prokaryotic organisms can 
be ion-based  (Brun et al., 2014, Ng et al., 2013). Based on findings present in this 
thesis it has been deduced that a supernatant of ascending concentrations of ZnO NPs 
can have an adverse effect on eukaryotic cells while allowing the growth and 
attachment of cells when these NPs are coated onto a surface. Studies were carried 
out in on an attempt to understand the quantity of ions released into the surrounding 
medium and whether this release is consistent with the antimicrobial activity of 
nZnO at different concentrations. In fact further experimental results indicate that 
cytotoxicity of nZnO of sizes ranged between 30-60 nm (identical to that of this 
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study), corresponds to that of solutions of Zinc chloride (Miao et al., 2010).  Since 
Zinc ions are the main cause of antimicrobial activity in a solution of ZnCl, these 
results are fascinating and suggest that ion release could play a major role in the way 
that these NPs cause both their bactericidal and cytotoxic effects. However the 
majority of studies have overlooked the ability of nZnO coatings to release ions, the 
aim for conduction of the following studies was to analyse this and compare the 
results to that of ion release of suspended ZnO NPs.  
 
1.2 ROS generation 
Reactive oxygen species (ROS) are considered to be one of the predominant 
mechanisms by which NPs cause bacterial damage. Studies suggest that H2O2 is the 
dominant species behind such ROS-based antimicrobial activity (Dwivedi et al., 
2014). Mechanistic experiments with oxides have yielded numerous and 
contradictory results. Conducted experiments on magnesium oxide (MgO) NPs 
(Makhluf et al., 2005) suggest that because of the presence of this metal oxide, ROS 
production and thus membrane damage is possible, although alternative mechanisms 
of actions such as direct contact related to damage to bacteria were also proposed. 
Other studies indicate that slurries made from powders of ZnO and MgO can 
independently release hydrogen peroxide (Sawai, 2003) While others suggest that 
ROS generation is not exclusively responsible for the antimicrobial activity of NPs 
and various other factors may be involved (Tam et al., 2008) . The production of 
H2O2 was shown to be directly related to an increase in concentration of NPs (Sawai 
et al., 1996). The physical presence of NPs in suspension also allows direct contact 
killing (Vargas-Reus et al., 2012) that does not allow an accurate quantification of 
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other factors involved. The following study attempts to provide evidence for the 
involvement of hydrogen peroxide in the antimicrobial activity of nZnO particulates.  
1.3 Nano-coating stability 
Bone implants within the body are exposed to variety of forces such as bending, 
torsional, axial compression, axial tension and shearing forces (Isidor, 2006). Given 
the fact that nano-based coatings are being proposed in the current study, one can 
investigate the effect of the dynamic environment present within the structure of the 
bone. This dynamic environment of forces also consists of biological components 
such as blood and marrow. The present study is an innovative method, designed to 
observe the shear stress/forces applied to a surface by these biological components. 
This is an important factor because more often than not, coated surfaces are prone to 
degradation when positioned within bone. Naturally, metal corrosion is a 
multifactorial phenomenon and depends upon mechanical, geometric and other 
important parameters. This often causes the release of debris into the surrounding 
environment, these are often metal based and nano in size (Jacobs et al., 2003). The 
present study is an indirect but innovative attempt to observe the effects that the 
physiochemical environment might have on a surface of an implant. This 
investigation utilises the function of a 3D printed model in order to create a prototype 
to test the present hypothesis.    
1.4 Pattern-based coated samples 
Patterned-based coatings have been used in relation to nHA in recent years (Gu et al., 
2012). However, patterned based investigations are  almost exclusively applied to  
nHA which solely serves to enhance osteoblast adhesion and proliferation (Munir et 
al., 2012). Furthermore, various studies claim that ceramic based micro-patterns are 
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able to promote bone formation more than the conventional coatings (Halai et al., 
2014). Apart from the biological response of cells to a patterned based coating, the 
hypothetical advantage of patterns is the potential of being less toxic when detached 
from the surface. It can be hypothesised that if the total surface area of prosthesis is 
taken into the consideration, then upon removal or a possible revision surgery, less 
surface detachment of a coating can be observed. It is known that NPs can travel 
throughout the body and into many organs and while not highly toxic and often 
cleared from the body via excretion  at moderate concentrations (Baek et al., 2012), 
they can accumulate and cause gene alterations, inflammatory responses among 
many other undesirable side effects (Balasubramanian et al., 2010).  
2. Nano-ZnO ion release capability  
2.1 Methods 
2.1.1 Suspension-based 
Different concentrations (100 µg/mL, 500 µg/mL, 2500 µg/mL and 10000) of NPs 
were incubated at 37°C for 1, 5 and 10 days in 3 mL of deionised water (dH2O) and 
subsequently centrifuged at 50,000 rpm for 20 min in order to separate the NPs from 
the supernatant. Half of the samples for suspension supernatants were filtered using 
0.25 µm filters (Millex® syringe filter units).  
2.1.2 Coated 
For coated samples, concentrations of 2500 µg/mL, 5000 µg/mL and 10000 µg/mL 
of nZnO were chosen as coating concentrations. Glass samples were coated and 
prepared as stated in previous chapters. Duplicate coated nZnO substrates were 
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placed in tubes containing 3 mL of dH2O at 37°C.  In order to increase the chances of 
detecting any ion leaching from the surface of the substrates. 
 
2.1.3 Ion chromatography 
NP supernatants (filtered along with unfiltered) were measured using ion 
chromatography (Dionex ICS-1000 cation system). The system uses an isocratic 
pumping method that has electrolytic suppression to minimise background counts. 
Analysis times can vary depending on the number of samples used and ions of 
interest. Vials of 500 µL were filled with the supernatant content and placed within a 
sample rack for measurement using the AS50 autosampler. The ion release data was 
transferred to a computer and analysed. 
2.2 Results 
Findings indicate that filtering the supernatants had a positive effect on detection of 
Zn2+ ion release. An increase in ion release for filtered supernatants was observed in 
ascending incubation periods. This phenomena was not observed for unfiltered 
samples, indicating a possible need for further separation of NPs and the 
supernatants.  
Ion release was detected for all concentrations during days 1 and 5 and only on day 
10 was there a gradual peak observed for Zn+2 release with filtered supernatants. The 
difference between the ion release from the coated surfaces and suspended NPs was 
clearly evident (Figure 62) as the ion release for coated samples was considerably 
lower than that from suspension supernatants. 
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Figure 62 - Ion release measurements of supernatants of A) coated 
samples, B) unfiltered and C) filtered nZnO suspensions. All samples 
were compared to dH2O (Control) that was incubated alongside all 
samples for the relevant period of time. n = 3 (for each condition and 
concentration). 
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2.3 Discussion 
These provisional findings indicate that ion release from a nano-coated surface is 
minimal as compared to suspension-based ion release. Therefore it seems that “ion 
release” plays a limited role in the antimicrobial activity of nZnO via coated 
substrates. An important distinction between the stable NPs and when in suspension 
needs to be made. Current findings indicate that nZnO coated samples submerged 
into suspensions of bacteria, showed significant bactericidal activity as compared 
with innocuous coated NPs and the uncoated samples (Memarzadeh et al., 2012). If 
the assumption for this activity is based solely upon ion release, then this is a 
contradictory finding, since not much is released into the surrounding environment 
from the coated samples. The same deduction cannot be made for suspended NPs 
and their mode of antimicrobial action and ion release is indeed one of the main 
mechanisms for their antimicrobial activity.      The results can however shed some 
light on the fears of “excess ion release” that could cause cytotoxicity to eukaryotes 
such as osteoblasts. The antimicrobial activity of NPs and their mechanistic 
behaviour are extremely complex and further evaluations of evidence are required in 
order to achieve a firm conclusion.  
2.4 Conclusion 
It is important to distinguish the difference between the ion release of individual NPs 
in suspension and those that are coated onto a substrate. Here preliminary evidence is 
presented that coated NPs release lower amount of ions into their surrounding 
environment. This could have important implications as to determine the main 
mechanism underlying the antimicrobial property of coated nZnO particulates.  
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3. Hydrogen peroxide release 
3.1 Methods 
3.1.1 Nanoparticles 
Nano-ZnO particulates were prepared at concentrations of 10,000, 5000, 2500 and 
1000 µg/mL in PBS (Table 5). All concentrations were thoroughly sonicated and 
then vigorously shaken at 2500 rpm in order to insure a stable suspension.     
 
3.1.2 Bacteria 
Species of bacteria used were: S. aureus (Oxford   strain; NCTC.  6571) and E. coli 
(NCTC 9001). 
3.1.3 Hydrogen peroxide assay 
Using a hydrogen peroxide colorimetric detection kit (Hydrogen Peroxide Assay Kit 
- abcam UK, ab102500) the release of H2O2 into the surrounding medium was 
quantified. Samples were prepared and analysed based upon the assay protocol 
provided by the manufacturer.  
Hydrogen peroxide release was analysed by observing the difference in release 
between multiple concentrations of nZnO suspended in PBS (Table 5), similar 
analysis was carried with the bacterial species exposed to the different concentrations 
of nZnO. Bacterial species were at populations of ~ 107/ mL suspended in PBS. All 
experiments were carried out at room temperature.  
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3.2 Results 
Exposure of S. aureus resulted in no increase in concentrations of hydrogen peroxide 
(Figure 63). In addition to these results at concentrations of 10,000 µg/mL of nZnO 
in PBS, increasing quantities of superoxide was quantified. The outline for all 
bacterial suspensions in NP supernatants is described in table 4.  Superoxide release 
from suspensions of E. coli with nZnO was evident and can be quantified using the 
suspensions at 5000 µg/mL and 10,000 µg/mL nZnO. The release profile for 
hydrogen peroxide differs between S. aureus as compared to that of E. coli. No 
visible H2O2 release for nZnO concentrations of 5000 µg/mL and lower was 
observed; however minimal release was observed for the 10,000 µg/mL 
concentration of nZnO (Figure 63).  
 
 
 
 
Table 4 – Supernatants for different concentrations of suspended NPs were mixed with O.D. 
adjusted bacterial suspensions. NP supernatants in PBS were also tested for hydrogen peroxide 
release without exposure to bacteria. The black arrows annotate the mixing action, i.e. E. coli 
suspension + 1000 µg/mL NP supernatant.  
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3.3 Discussion 
The present preliminary results indicate that hydrogen peroxide release differs when 
E. coli is compared to S. aureus. NP suspensions elicit less H2O2 release when 
exposed to S. aureus as compared with E. coli. This in turn indicates that S. aureus is 
somehow able to break down the production of this reactive oxygen species 
(Mandell, 1975). The current observation is strengthened by studies demonstrating 
that this break down is possibly based upon the activity of catalase activity produced 
by S. aureus (Makhluf et al., 2005).  
3.4 Conclusion 
According to these findings, NPs are able to independently produce H2O2 and that the 
amount released into the surrounding environment differs when exposed to either S. 
Figure 63 - Comparison of H2O2 release between S. aureus and E. coli when exposed to 
different concentrations of ZnO NP. ZnO nanoparticle suspensions and bacteria (NP s.a  and 
NP e. coli) were also tested for H2O2 release independently. The red line depicts the controls, 
n ≥ 3, all concentrations on the Y axis are µg/mL. 
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aureus or E. coli. More thorough studies are required to establish a coherent 
mechanism for these effects. 
4. Coating stability test  
4.1 Methods 
4.1.1 3-D printing 
Ultimaker 2, a 3-D printer, (UCL, Institute of making) was used to print all the 
prototypes produced for the present experiments. A cylinder like structure was 
designed (CATIA VR3) in order to serve as the container of test samples. The 
programmed software was then transported to the 3-D printer and a prototype was 
printed using polylactic acid (PLA) in a layer by layer bases. A 3-D printer allows 
for great freedom as it allows for formation of each layer as a hotplate melts the 
polymer at a specific temperature (melting temperature of PLA is ~ 200°C) and 
subsequently building the forthcoming layers on top. The density of PLA used was 
chosen to be at 100% in order to allow the construct to have water-tight properties.  
 
4.1.2 Coated samples 
Glass samples were coated using concentrations of 10,000 µg/mL of nZnO and 
prepared as previously explained in Chapters 3.  
 
                                                  4.1.3 Coating stability  
With an aim to measure the effect of shear stress on the surface of the nano-coated 
samples, the cylindrical prototype was devised that allowed careful monitoring of the 
nano-coated surfaces. The 1 cm2 nano-coated sample along with a non-coated sample 
was placed in each pocket, carefully designed in order to ensure the coated surfaces 
was positioned inside pockets created  towards the inner region of the cylinder 
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(Figure 64). A magnetic stirrer was placed at the bottom of the cylinder in order to 
provide an artificial flow rate that allows for the measurement of shear force applied 
onto the NPs on the sample surface and eventually the measurement of the stress 
required for the particulates to be worn off the surface.   The flow rate of the fluid 
can be measured (Day 1, 5 and 10)  using a Laser Doppler Anemometry (LDA); that 
is normally used to measure the velocity of any specific liquid. Simulated body fluid 
(SBF) and olive oil were chosen in order to compare their qualities. Studies have 
confirmed that the viscosity of bone marrow differs in various bone types and also 
temperature dependent. Overall a fluid such as olive oil has rheological properties 
that are closer to that of bone marrow (Gurkan and Akkus, 2008).   Olive oil has an 
increased viscosity (81 cP) as compared with SBF and therefore changes can be 
observed when applied to the nano-coated surface. The substrates were seated into 
the hollow pockets in order that the surface will be exposed to the moving fluid 
which can potentially simulate aspects of what occurs in vivo. In order to fill the 
space within the cylinder, three elongated arms were designed, each one having a 
pocket positioned at its extremity. These pockets were positioned in symmetrical 
fashion so that when samples are fixed within each one, equal exposure to the shear 
stress is taken place, essentially allowing all three samples to be processed at the 
same instance.  
Each pocket with its sample is supported by an arm with a thickness of 10 mm and 
each of these three arms has a distance of approximately 10 mm from the centre of 
the cylinder.  The substrate has the size of 1 cm2 and less than 1 mm thick. Therefore 
the pocket needed to be slightly bigger and was designed in order that nano-coated 
samples are placed within it without any visible damage to the surface.  
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The dimensions of the pockets were: 10.5 mm and thickness of 1 mm and the outside 
of the pocket are 13 mm high, 12.5 mm wide and 3 mm thick. Hence, the substrate 
can fit into the pocket. The hollow space on the pocket is 10 mm high and 8 mm 
wide. 
 
4.2 Results 
The initial concept of the present investigation was to 3-D print a prototype (Figure 
64) that is ultimately used to utilise a laser technology in order to measure the flow 
rate near the surface of the nZnO coated samples. However because of the nature of 
the material (a murky clear PLA) and its relative thickness, an accurate measurement 
could not be achieved using this technique, leading to the abandonment of laser 
guided flow rate measurement. Other options such as applying some form of 
coloured dye that would travel with the fluid in order to provide a visual 
approximation, followed by a measurement of fluid mobility nearby were proposed 
but discarded because environmental factors which lead to lack of dye control. 
Results for stirrer based immersion studies indicate that when placed in olive oil 
(Figure 65) at a fixed flow rate of 80 rpm, nano-coatings start to wear off after a 5 
day period. This phenomenon was not observed with coated samples positioned in 
the SBF filled chamber. 
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Figure 64 - The figure on the left represents the initial design of the prototype and the figure on the 
right is the final product. Using a stirrer the fluid within the chamber is moved and shear stress is 
applied to surface of each sample separately. A magnetic stirrer placed at the centre of the chamber is 
not the best option because it allows for potential errors in calculating the exact fluid flow near the 
nano-coated samples. A stirrer that allows for a uniform fluid flow is therefore a suitable future 
alternative.  
Figure 65 - The cylindrical prototype filled with olive 
oil and loaded with samples. The viscosity of olive 
oil is approximately similar to that of the bone 
marrow and therefore utilised. The motion of the oil 
within the chamber allows for close contact with the 
surface of coated NPs. 
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4.3 Discussion 
The mechanical stability of a coating is of utmost importance for future medical 
implants. The present findings provide evidence for diversity of strength and 
stableness of our coatings. Furthermore by comparing the in vitro physiochemical 
effects (detachment of the NPs from the surface) that these environments instigate 
upon the coatings we can formulate an approximate idea about their stability. A 3D 
printed model allows for rapid prototyping. This permits for designing a device that 
permits researchers to manifest their ideas faster and relatively cheaper. While 
limited similar studies have been conducted before, there is much of evidence for an 
enhanced cellular behaviour in systems where use liquid flow enhances cellular 
attachment (Jacobs et al., 1998, Bancroft et al., 2003). It could be envisioned that a 
similar method could be utilised to measure the mechanical integrity of a coating. 
This could be achieved by analysing the shear stress applied to multiple surfaces for 
prolonged periods.  A similar prototype, based upon the cylindrical nature of the 
current model is now being designed and used by the present research team 
(unpublished work) to study and observe the osteoconductive nature of nano-coated 
Ti samples in the presence of decellularised S. domesticus bone discs.  
4.4 Conclusion 
Nano-coatings can be highly antimicrobial and also enhance biocompatibility, 
however their stability is understudied. The current investigation adds insight into the 
novelty and provides some evidence that can be expanded into a larger area of 
investigation.  
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 5. Osteoconductive patterned nZnO  
 
5.1 Methods 
5.1.1 Patterned-coated samples 
All samples were created as explained in previous chapters.  Individual the patterned 
regions (round in shape) on the glass slides comprised of 204 -210 of individual 
square shaped patterns. These square shaped patterns had equal sides, each 
measuring to150 µm.  Furthermore, there were four patterned regions present on 
each glass sample (Figure 66).   
 
5.1.2 Cell culture 
A relatively small number of previously cultured UMR-106 cell lines (1 × 103 cells) 
were placed at the midpoint of the glass samples (n =3), between the patterned 
regions. All seeded samples were placed in a 12-well plate and incubated overnight 
at 37ºC, 10% CO2 in DMEM (5% FCS, 1% P/S). Proliferation assay: AlamarBlue 
(abcam, UK) was used to quantify osteoblast proliferation (Figure 67) on nano-based 
micro-pattered surfaces. Glass samples were used for each time point (Days 1, 5 and 
10). Controls were glass samples with no nZnO micro-patterns. Each sample was 
then removed and prepared for SEM (procedure explained in previous chapter 2). 
5.2   Results 
The nZnO-patterned coated surfaces revealed that organised homogenous structural 
relics can be coated onto substrates (Figure 68 – 70). These assemblies are almost 
always agglomerations of NPs because they are confined into a limited space 
provided by the grid (Figure 66). Considering the fact that controls in the current 
experiment were chosen as plan glass, a significant (p < 0.05) difference in 
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proliferative activity was observed after day 10 of incubation. This difference was 
also significant for day 5 but after 24 h of incubation no change between the two 
samples was observed (Figure 67). Closer analysis of each patterned region indicates 
that osteoblast-like cells have majorly adhered to coating regions as opposed to 
regions between the small square shaped coatings. This was evident at regions where 
there were lower number of cells per coated region, often with multiple osteoblasts 
adhered onto the squared regions (Figure 68). Furthermore, each square shaped NP 
pattern contains hundreds of tiny circular agglomerations of NPs, each with a 
diameter of ~ 4.5 – 5 µm, all concentrated at the centre of each square structure and 
only visible in its extremities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 66 - A hypothetical diagram showcasing the possible osteoconductive ability of nZnO 
coatings. The patterned structures can hypothetically attract osteoblasts, showing the ability of 
nZnO as a patterned based coating. 
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Figure 67 - An independent experiment comparing the proliferation of osteoblasts on 100% 
nZnO patterned coated samples compared to uncoated glass samples. While no significant 
changes are observed after days 1 and 5, a significant change in proliferation is observed on 
day 10 between cells cultured on nZnO and non-coated samples. n=3, ±SEM, p < 0.05.  
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Figure 68 - Squared shaped nano-patterned coatings with osteoblasts seeded upon. The magnified 
region represents the structure of nZnO when coated as patterned structures. Each square shaped 
structure (150 µm) consists of smaller circular regions (5 µm). Osteoblasts are predominantly 
adhered to these coated regions (highlighted by the black arrows).  
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Figure 69 – An osteoblast spreading its filopodia onto nano-coated regions. The coated regions seem 
to be a combination of circular regions that make up the coated regions (black arrows and red lines). 
These regions are possibly encapsulated nanoparticulates inside each droplet formed by the EHDA 
process.  
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Figure 70 - Electron micrograph of osteoblasts attached onto the surface of a nZnO patterned 
structure. The arrangement of cellular attachment indicates that these cells prefer the patterned 
surfaces compared to the normal glass surface.  
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5.3 Discussion 
The novel finding for osteoblast selectivity towards nZnO-patterned regions can 
provide insightful information as to how eukaryotic cells respond to different 
patterns of NPs in general. The underlying mechanisms that lead to such behaviour 
are currently unknown. However evidence presented in this thesis and other studies 
indicate that this is potentially related to zinc ions being present in the immediate 
environment of cells (Ito et al., 2002, Wang et al., 2010). However, within an 
aqueous medium, ions can potentially dissipate throughout the surface of the sample 
and therefore the nano-structured surface should not be the only region where cells 
generally prefer to adhere. It is thoroughly possible that the previous effect in 
combination with the hypothesis that nano-surfaces can promote cell growth (Pan et 
al., 2012) could contribute to this novel behaviour. The nanophase physical structure 
and the micro-patterns of these coatings maybe preferred by osteoblasts because of 
their increased surfaced area to volume ratio (Christenson et al., 2007, Jeon et al., 
2010) as compared with the rather non-porous and smooth surface of glass or 
titanium.  
5.4 Conclusion 
Patterned systems can be a useful tool for future coating based implants. Selective 
attachment of osteoblasts to a specific area could help in the understanding of 
cellular behaviour in addition to helping the advancement of future goal directed 
biomaterials. Studies such as further migratory studies can be devised to analyse and 
establish a more efficient osteoconductive coating.  
 
 
163 
 
                                                             Chapter 5 
1. General discussion 
An ideal bone implant or prosthesis would allow bone growth on the coated surface 
of the implant, together with preventing the formation of a bacterial biofilm. The 
antimicrobial ability of an implant is highly relevant to the present study. A recent 
important report published by world health organisation (WHO - 2014) indicates that 
common infections by species such as E. coli and S. aureus are increasingly difficult 
to treat both within the public and medical sectors of society. This report points out 
that bacterial resistance is an “increasingly serious threat to global public health” and 
that if not controlled, the spread of infection can lead to prolonged hospital stays, 
major economic and social costs as well as a greater risk of death. The topic, 
presented in this thesis is therefore of upmost importance, not only because it 
provides the reader with an insight into a novel coating technique and material for 
future bone implants but because it involves a thorough examination of the effect of 
coated NPs on bacteria. The idea that coatings should be implemented onto surfaces 
to enhance their biological activity in order to make them multifunctional has existed 
for many years (de Groot et al., 1998). However, nanostructured coatings are a very 
recent phenomenon (Wagner et al., 2006). For bone related assignments, the porous 
structure of the coating is of outmost importance as it provides osteoblasts with 
regions to adhere to in order to proliferate and finally differentiate and generate a 
suitable ECM that allows healthy bone formation. However, many medical coatings 
used in the medical sector are either HA based or consist of other material that only 
allows better bone formation. The current projects, along with various others are 
changing this unidirectionality of nano-coatings. The evidence presented in the 
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current study suggests that there is room for improvement. Because bone does not 
have a natural tendency to combat different infections, coated NPs that are able to 
control the spread of biofilm formation are of great interest. Our investigations show 
that a nanoparticulate such as ZnO is capable of providing such advantages in 
addition to accommodating the additional role of being a surface that allows 
osteoblasts to adhere. This finding was based upon the employment of techniques 
designed in order to optimise observations. Of course, many methods employed in 
the present investigation are introductory and can be improved upon. At the end of 
each chapter, shortcomings that allow for these improvements have been included. 
While the bactericidal studies are performed with accuracy and precision, calculating 
values for MIC and MBC of a material that is not soluble in an aqueous environment 
can prove difficult. Some NPs may be soluble in liquid and this has an effect on their 
relative toxicity towards living organisms (Studer et al., 2010). Therefore 
suspension-based studies are only useful to observe and analyse the superficial 
antimicrobial activity of a nanoparticulate over time. In other words, utilising them is 
an initial step in determining their initial antimicrobial capability. Coating nZnO on 
glass samples provided much more insight as regards to their biocompatibility and 
antimicrobial activity. Studies showed that these coatings exhibit much antimicrobial 
potential as samples were submerged into a known concentration of bacteria 
suspended in PBS. This was encouraging and future studies on nZnO coated material 
led to investigations relating to their biocompatibility. In studies related to 
multifunctional devices, some functions need to take precedence over others. In the 
present investigation it is the biocompatibility that is of upmost importance. Some 
studies related to ZnO NP indicate its toxicity (Lin et al., 2008), therefore relevant 
studies were carried out to confirm these findings. At this phase, the intention was to 
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choose the correct concentration of nZnO that was not toxic to osteoblasts, or at least 
allowed for their adhesion to the coated surface, without further detachment. High 
concentrations (10,000 µg/mL) were deliberately used to establish if there were any 
detrimental effects towards cells. In addition, this chosen concentration of nZnO, 
would be made into a composite coating with the aid of nHA in order to potentially 
boost the osteoconductivity of the material while retaining the antimicrobial 
property. The surprising outcome was contradictory to the initial hypothesis. The 
implemented high concentrations of nZnO accommodated for attachment of 
osteoblasts.  
2. Biocompatibility properties 
There are various definitions for biocompatibility but this term is best explained by 
Williams, 2008 as “a system allowing for desired beneficial cellular or tissue 
response in relation to a medical related therapy” (Williams, 2008).  This description 
can restfully be applied to findings explained in this thesis. The present data shows 
that utilisation of NPs as coatings can hinder material toxicity. These findings 
focused on cell morphology, mitochondrial activity and membrane integrity. An 
immediate cue for understanding cell health is an extreme change in morphology 
coupled with compromised adhesive properties (Nakayama et al., 2005, Shi et al., 
2009). Present findings suggest that there is no change in morphology between cells 
adhered to an uncoated sample as compared to samples coated with nZnO. In 
addition, osteoblasts stained for paxillin showed no change in expression between 
uncoated, composite and nZnO coated samples, reinforcing the suitability of nano-
coated surfaces as biocompatible materials. Furthermore, Our investigations 
(Memarzadeh et al., 2015) provide further evidence for increased proliferative and 
decreased cytotoxicity for osteoblasts adhered to the surface of nZnO coated 
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substrates.  Recent findings also indicate that incorporating a specific concentration 
of nZnO particulates onto a nano-phased titanium sample results in enhanced cellular 
adhesion and reduced bacterial adhesion (Elizabeth et al., 2014). Further evidence for 
biocompatibility and osteoconductivity of nano-coatings were presented as patterned 
based coating systems. Findings suggest a novel observation where when low in 
numbers osteoblasts almost exclusively adhere to nano-coated regions. It is often 
claimed that cells can discriminate subtle topographical changes and are highly 
sensitive to both surface roughness and chemistry. The unique properties of a nano-
coated surface may contribute to cellular affinity by attracting certain proteins onto 
its coating material (Oh et al., 2006) and hence may promote region specific 
osteoblast proliferation and differentiation. 
3. Antimicrobial properties 
It has been shown that the antimicrobial properties of nanoparticulates differ 
depending upon their size, method of synthesis and even their location (Allaker and 
Memarzadeh, 2014). The change in their application from in suspension to coated 
also affects their relative size and physical properties. Because of the continuous and 
constant nature of the coating process, NPs are built up layer upon layer. This in 
effect does not allow the easy exposure of individual nanoparticulates to the surface 
of microorganisms. If coated for a prolonged period, the lower layers of NPs will 
seldom have contact with an external environment, other than their immediate 
surroundings. Based upon the present findings, it can be stated that increasing 
coating time is inversely related to the antimicrobial activity of the coatings. Coating 
time also leads to the mechanical instability of coated regions, which can potentially 
lead to production of wear products if implemented into bone.  Therefore, a thin 
coating is an ideal approach. The present findings indicate that nZnO alone (without 
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the aid of nHA) is a good candidate for potential future coatings. This is because it 
has both suitable antimicrobial as well osteoconductive properties. A brief discussion 
as regards the hypothetical mechanisms underlying both of these important 
properties is given below: 
1) Ion release: 
The results of the current study suggest that there is an element of ion related 
antibacterial activity. It is suggested that ion release is accountable for bactericidal 
effects in conjunction with ROS. Studies have confirmed that bacteria possess 
specific transmembrane proteins that are able to pump Zn+2 ions into the cell and 
cause toxicity. It has also been demonstrated that 500 µg/mL of ZnO nanoparticles 
can display significant antimicrobial activity (Li et al., 2011). In normal 
circumstances internal Zn+2 would not damage the bacteria. The mechanisms in 
which ZnO nanoparticles release their ions are as yet unknown, however the 
chemical reaction between ZnO nanoparticles and protons in suspension can 
potentially initiate the ion release. This is dependent on two main factors: the pH of 
the suspension and size of the NPs. Therefore, nZnO are able release ions when 
reacting with free protons available in solution.  The reaction responsible can be 
depicted as: ZnO + 2H+   Zn2+ + H2O. A lower pH in a suspension seems to 
increase the ion release and a high pH results in a significant decrease (Yang and Xie, 
2006). Findings in this study suggests that suspended nanoparticulates are able to 
release ions at very high concentrations, however  nano-coated samples release trace 
levels of Zn2+ at the same concentration. Furthermore based upon other comparative 
studies performed and since PBS and ABS were used in the current studies (pH at 
approximately 7.2), it would be unlikely that the bactericidal effects are 
predominantly ion related (Raghupathi et al., 2011, Yang and Xie, 2006).  
168 
 
2) Contact killing: 
Most bacteria have a negative charge on their membrane (Koprivnjak and Peschel, 
2011) and this includes the species used in the current study. This property can be 
used to an advantage when undertaking antimicrobial studies. It has been shown that 
nZnO in a suspension are attracted to the membrane of E.coli due to possible 
electrostatic forces between the bacteria and the NPs (Zhang et al., 2008). This 
suggests that ZnO NPs can form strong dipole conditions when in aqueous 
environments. It is suggested that interaction between bacteria and the surface of 
these NPs can cause the destruction of the cell wall /membrane, instigating a forced 
introduction of foreign molecules (genetic material, proteins and possibly the 
nanoparticulates) into the cell, causing cell death. The effects caused by these NPs 
could be related to their physical structure as well as their surface area. The nZnO 
used in the current study possess many rod shaped structures as well as sharp edges 
that could contribute to bacterial damage. Furthermore other studies suggest that 
placing nZnO in a non-aqueous medium would result in an oxygen deficient surface 
that can interact strongly with the negatively charged cell membrane, leading to 
membrane damage. In the time based bactericidal studies, all NPs and bacteria were 
in suspension and in an aqueous environment. Although efforts were made to 
maximise nanoparticle-bacteria interaction, most bacteria would naturally remain in 
suspension longer than the NPs. This makes contact killing improbable.  However, 
the direct contact studies as regards to coated NPs show an increase in the 
bactericidal properties as the percentage of nZnO is increased on the surface of the 
samples, indicating a possible contact related bactericidal activity when these NPs are 
fixed and stabilised on a surface. 
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3) Reactive oxygen species (ROS): 
ROS are thought to be essential in the antimicrobial activity of nanoparticles. This is 
particularly applicable to metal oxides. These oxides are thought to release H2O2 
(hydrogen peroxide) and other reactive oxygen species (Yamamoto, Xia et al., 2008, 
Premanathan et al., 2011) that are toxic to bacteria. It has been observed that 
hydrogen peroxide can interact with the membrane proteins of bacteria either by 
entering the cell via the surface proteins or by being created within bacteria and 
causing direct damage to DNA. A recent study (Zhang et al., 2008) suggests that the 
NPs with an average size of 93 nanometres, demonstrate their antimicrobial 
properties via the route of ROS release. They also show that compared to the 
“micron” size, the “nano-size” particles of ZnO have enhanced antimicrobial activity, 
indicating that the “nano-scaled” particles may play an important role in releasing 
more ROS and therefore an enhanced antimicrobial effect. Claims have been made 
that oxidative stress-related genes have been up-regulated in the presence of ZnO 
nanoparticles because of ROS release. This is evident in a study carried out on a 
gram negative bacterium (Campylobacter jejuni). This study shows that certain 
oxidative and general stress-related genes have been up-regulated in the presence of 
ZnO nanoparticles (Xie et al., 2011). Moreover it is also claimed that ROS release 
from ZnO nanoparticles in a moist environment can lead to biofilm penetration 
(Shrestha et al., 2010).  
The accumulation of similar scientific endeavours indicates a major shift from 
conventional methods (whereupon the utilisation of small molecules such as 
antibiotics were the suitable choice for infection prevention) to utilisation of 
innovative biomaterials that offer promising results which will potentially lead to 
addressing multiple clinical challenges that currently require bone prostheses.  
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4. Conclusions 
The present study offers strong evidence in support of coated and stabilised nZnO as 
a potential antimicrobial agent for future medical device applications, particularly as 
a bone implant coating material. Further analysis of zinc oxide NPs would provide 
further confirmation as to its biocompatibility and provide mechanistic insight. 
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